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CHAPTER 1 
 
Introduction 
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Introduction 
 
In female mammals, meiosis is initiated prenatally and oocytes (immature germ 
cells) remain arrested for long periods at prophase of the first meiotic division within the 
ovary, by signals from the surrounding granulosa cells.  With the onset of puberty, the 
arrest is released as a result of the pre-ovulatory surge in luteinizing hormone (Figure 1) 
mediated by granulosa cells surrounding the oocyte, activating the maturation promoting 
factor (MPF) within the oocyte.  The arrest of oocytes at meiosis I can be mimicked in 
vitro by dibutyryl cAMP, represented in Figure 1.  MPF triggers the resumption and 
completion of meiosis I by forming a first polar body, leading to a mature, haploid egg 
[1-4] that remains arrested at metaphase of meiosis II until fertilized by a haploid sperm 
to produce the diploid zygote, along with extrusion of second polar body.  
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Figure 1. Schematic representation of the process of mouse oocyte maturation.  
GV: Germinal Vesicle; GVBD: Germinal Vesicle Break Down; LH: Luteinizing 
Hormone; dbcAMP: dibutyryl cAMP. 
 
Figure 2 shows a normal mouse oocyte with an intact germinal vesicle (GV; 
oocyte nucleus) and a typical, metaphase II-arrested mouse egg matured from an oocyte 
following germinal vesicle breakdown (GVBD).  Both oocytes and eggs are surrounded 
by a protective, membranous covering – the zona pellucida (Figure 2), known to contain 
sperm-binding proteins critical to the process of fertilization.  Failure of oocyte 
maturation has been documented in animal models and must be considered when human 
female infertility is examined [5]. 
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Figure 2. Morphology of oocytes and eggs of the adult mouse.  
A: Schematic structure of an oocyte. B: Schematic structure of an egg. C: Bright field, 
equatorial image of an oocyte. D: Bright field, equatorial image of an egg associated with 
a first polar body.  
 
The 14-3-3 proteins (YWHA or Tyrosine 3-Monooxygenase/Tryptophan 5-
Monooxygenase Activation proteins) are a highly conserved family of acidic proteins 
expressed abundantly and ubiquitously in a wide variety of eukaryotic cells and 
organisms ranging from plants to mammals [6].  They were first identified during a 
systematic classification of brain proteins [7].  The name ‘14-3-3’ was used to denote the 
elution fraction comprising these proteins after DEAE-cellulose chromatography and 
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their migration position after subsequent starch gel electrophoresis. These proteins are 
known regulators in important physiological and cellular events including metabolism, 
transcription, signal transduction, cell cycle control, apoptosis, protein trafficking, stress 
responses, malignant transformation and embryonic development. Over 200 proteins that 
may interact with 14-3-3 have been detected by proteomic and biochemical methods [8-
11]. This broad range of partners suggests a role of 14-3-3 as a general biochemical 
regulator. They are key regulatory proteins that may alter the activity of bound proteins, 
change the associations or interactions of the bound proteins with other proteins, protect 
protein phosphorylation, promote protein stability and/or alter the intracellular 
localization or destination of the bound protein. The role of 14-3-3 proteins in 
mammalian reproduction has not yet been completely known. My dissertation focused 
upon the isoform-specific expression, distribution and roles of 14-3-3 proteins during 
mouse oocyte maturation. 
The 14-3-3 proteins are a family of homologous proteins encoded by separate genes. 
To date, seven mammalian isoforms of 14-3-3 have been discovered and were named 
after their respective elution positions on HPLC [12]. The phosphorylated forms of 14-3-
3β and 14-3-3γ were initially described as 14-3-3α and 14-3-3δ respectively [13].  
Protein 14-3-3 exists mainly as homo- or hetero-dimers with a monomeric molecular 
mass of approximately 30 kDa [8]. It is known that different 14-3-3 isoforms can interact 
with the same ligand and so are somewhat interchangeable; however, although isoforms 
of 14-3-3 often bind the same protein, there are some indications that homodimers of 
different types or even heterodimers of 14-3-3 may have different roles in the regulation 
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or sequestering of proteins [14, 15]. Dimerization of 14-3-3s is important, because point 
mutations that disrupt 14-3-3 dimers can impair regulatory functions of 14-3-3s [16, 17].  
The 14-3-3 proteins have been shown to bind to various signaling molecules by 
phosphorylation-dependent mechanisms. They have been found to complement or 
supplement intracellular events involving phosphorylation-dependent switching or 
protein-protein interaction [10, 18]. The 14-3-3s bind to proteins containing phospho-
serine and phospho-threonine residues with RSXpSXP and X(Y/F)XpSXP motifs [19, 
20]. Most of the binding partners of 14-3-3 are phosphorylated, however, 
phosphorylation-dependent sites that differ significantly from these motifs have been 
reported [14], and some interactions of 14-3-3 do exist independent of phosphorylation. 
The effect of 14-3-3 binding has diverse cellular effect(s) depending on the nature of the 
ligand. Changes in phosphorylation status of the 14-3-3 binding motif on target proteins 
may result in changes in binding patterns. For instance, dephosphorylation of certain 
serine residues on target proteins may release the interaction with 14-3-3; likewise, serine 
phosphorylation may lead to 14-3-3-target interactions. Members of the 14-3-3 family of 
proteins play a central role in mitosis in mammalian cells and meiosis in amphibians, but 
their role in mammalian meiosis has not been entirely defined. 
This dissertation aimed at unraveling the differential expressions of 14-3-3 protein 
isoforms and their roles in the regulation of mouse oocyte maturation, involving three 
major projects: 
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I. Identification and distribution of 14-3-3 (YWHA) protein isoforms in 
mouse oocytes, eggs and ovarian follicular development 
Hypothesis: One or more isoforms of 14-3-3 proteins are expressed in 
mouse oocytes, eggs and in various stages of ovarian folliculogenesis. 
 
II. Investigation of isoform-specific interactions of 14-3-3 (YWHA) proteins 
with CDC25B phosphatase in mouse oocyte maturation 
Hypothesis: One or more isoforms of 14-3-3 proteins interact with 
CDC25B phosphatase to regulate mouse oocyte maturation. 
 
III. Determination of the requirement of 14-3-3η (YWHAH) in meiotic 
spindle assembly during mouse oocyte maturation 
Hypothesis: Protein 14-3-3η is essential for meiotic spindle formation by 
interacting with α-tubulin to regulate the assembly of microtubules. 
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CHAPTER 2 
 
Identification and distribution of 14-3-3 
(YWHA) protein isoforms in mouse oocytes, 
eggs and ovarian follicular development 
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Background 
 
Members of the 14-3-3 family are key proteins in a number of intracellular events, 
particularly those involving phosphorylation-dependent switching. The proteins bind to a 
diverse set of target proteins and alter cellular function by binding to and causing 
conformational changes in target proteins or modifying target protein interactions with 
other proteins. Of particular interest, 14-3-3 appears to be central to several aspects of 
vertebrate development and cell cycle regulation, including meiosis in amphibians [1,2]; 
however, the functions of 14-3-3 in mammalian reproductive organs and in gametes have 
not been completely elucidated. There is also interest in understanding the role of 14-3-3 
proteins in the regulation of oogenesis and the cell cycle during oocyte maturation and in 
early development. In addition, 14-3-3 proteins, by their participation in the regulation of 
the cell cycle, apoptosis, and tumor suppression, are important in normal growth and 
development as well as in cancer [3]. 
The 14-3-3 proteins are a family of highly conserved, homologous proteins 
encoded by separate genes. The name for the protein family is tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein family (YWHA). The 
14-3-3 name is still commonly used. There are seven mammalian isoforms of 14-3-3 
encoded by seven different genes: β (Ywhab), γ (Ywhag), ε (Ywhae), ζ (Ywhaz), η 
(Ywhah), τ (Ywhaq) and σ (Sfn) [4]. The 14-3-3 proteins exist as homo- or hetero-dimers 
[5,6]. It is known that different 14-3-3 isoforms can interact with the same ligand and so 
are somewhat interchangeable. Although different isoforms of 14-3-3 may bind the same 
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protein, there are some indications that homodimers of different types or even 
heterodimers of 14-3-3 may have different roles in the regulation or sequestering of 
proteins [7-9]. 
The roles of 14-3-3 proteins in the ovary may parallel function in other tissues. 
For example, 14-3-3σ is expressed at lower levels in cancerous cells in a number of 
tissues including adenocarcinomas of the ovary [3, 10]. However, specific descriptions of 
the roles of 14-3-3 proteins in the ovary are few. In female mammals, meiosis is initiated 
prenatally and oocytes remain arrested in an immature state at late prophase of the first 
meiotic division for long periods of time. This arrest is released as a result of the pre-
ovulatory surge in luteinizing hormone and oocytes resume the first meiotic division 
cycle and arrest at metaphase II of meiosis to form the mature egg. It has been suggested 
that, in mammalian oocytes, 14-3-3 binds to and regulates the cell cycle control protein 
CDC25B phosphatase (cell division cycle 25 homolog B), as it does in amphibian 
oocytes, to hold the cell in prophase arrest [11]. In another case, our lab showed that 14-
3-3 interacts with phosphorylated PADI6, a key maternal effect protein, in mature eggs, 
but not with unphosphorylated PADI6 in immature oocytes [12]. While such interactions 
have been examined in part, more information about specific isoforms is needed. It is also 
clear that many more cellular processes in the ovary and in the female gametes might be 
regulated by 14-3-3. As a pre-requisite for understanding the role(s) of 14-3-3 in 
mammalian female reproductive development and oocyte maturation, we must 
understand which cell types express which individual isoforms. The present study 
explores the various isoforms of this protein and the characteristic patterns of expression 
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in immature oocytes, mature eggs and in the various developmental stages of ovarian 
follicles in the adult mouse. 
 
 
Results and Discussion 
 
The 14-3-3 proteins in oocytes and eggs 
Immature, prophase I-arrested mouse oocytes and mature, metaphase II-arrested 
eggs appear to express all seven 14-3-3 isoforms. Three approaches were used to 
determine if these cells contained each of the isoforms of 14-3-3. The proteins in oocyte 
and egg extracts were examined by Western blotting after polyacrylamide gel 
electrophoresis; cells were fixed and viewed by indirect immunofluorescence, and also by 
immunohistochemical staining of cells within ovarian sections. All three approaches 
relied on a panel of antibodies that has been shown to be specific for the various 14-3-3 
isoforms. Martin and his colleagues [13, 14] described the generation of the panel of 
antibodies and used them to detect the major brain isoforms of 14-3-3. They confirmed, 
by several methods, the high specificity of each of these antibodies, which is due to the 
fact that the epitope for each antibody is mainly in the N-acetylated amino terminus of 
the different peptide immunogens. The panel of 14-3-3 isoform-specific antibodies was 
also used to identify the isoforms of 14-3-3 proteins expressed in human dermal and 
epidermal layers [15] and in adrenal chromaffin cells [16]. 
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Presence and relative abundance of 14-3-3 isoforms in oocytes and eggs determined 
by Western blotting 
Western blots of extracts from 200 oocytes or 200 eggs indicate the presence of 
six of the seven isoforms (Figure 1). These six isoforms of 14-3-3 were also detected in 
ovarian protein extracts by Western blotting. Protein 14-3-3σ could not be detected by 
Western blotting; however, it was identified in oocytes and eggs by 
immunocytochemistry and in ovarian follicle cells, including oocytes, by 
immunohistochemical staining. The inability to detect 14-3-3σ in Western blots may be 
due to the unsuitability of this antibody in recognizing a denatured antigen by Western 
blotting procedure. 
       
Figure 1. Immunoblots identifying 14-3-3 isoforms in extracts from mouse oocytes, 
eggs and ovaries. Proteins from cell lysates were separated by electrophoresis under 
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reducing conditions, transferred to membranes and probed with antibodies directed 
against the 14-3-3 isoforms indicated. Each isoform shown was detected in lysates of 200 
oocytes or 200 eggs. Protein extracts of ovaries and brain from adult mice are included 
for comparison. The 14-3-3 protein is approximately 30 kDa. 
 
It is interesting to determine the relative amounts of the 14-3-3 isoforms in 
immature oocytes and in mature eggs. Quantitative changes in total amount of specific 
14-3-3 isoforms could provide insights into the regulation of oocyte maturation or other 
aspects of development. Such a comparison is possible as each experiment examines 
proteins from the same number of oocytes or eggs (200 cells) loaded onto two lanes of 
gel and the proteins are simultaneously transferred to a membrane and probed with the 
same antibody and Western blotting reagents. The qualitative comparison of one such 
experiment is shown in Figure 1. This experiment was repeated two additional times and 
a relative comparison was drawn for each isoform (Figure 2). The proteins 14-3-3β, 14-3-
3ε, 14-3-3η, and 14-3-3ζ appear in lesser amounts in mature eggs than in immature 
oocytes. For example, a marked decrease in the 14-3-3β isoform after maturation of 
oocytes into eggs is observed. On the contrary, amounts of 14-3-3γ and 14-3-3τ were 
found to increase following oocyte maturation. It should be noted that, in these 
experiments, it is only possible to make quantitative comparisons for a single isoform and 
not between different isoforms as the isoform-specific antibodies may have different 
affinities and therefore different intensities on a Western blot.
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Figure 2. Comparison of the relative abundance of individual 14-3-3 isoforms in 
immature oocytes and mature eggs. The relative abundance of each individual isoform 
is based on the integrated densities of bands obtained from immunoblots (see Methods). 
Three experimental immunoblots were prepared for each of the six isoforms shown. In 
each experiment, for one of the isoforms, protein extracts from 200 oocytes and 200 eggs 
was analyzed after electrophoresis and immunoblotting on the same blot. For every blot, 
the density of the band for oocyte extracts was normalized to 100% and the density of the 
band for eggs is given as a percent with regards to the normalized oocyte value. 
 
 
 
18 
 
 
 
Expression of 14-3-3 isoforms in oocytes and eggs determined by 
immunofluorescence 
Immunofluorescence microscopy confirms the presence of all seven 14-3-3 
isoforms in oocytes and eggs (Figure 3). Oocytes and eggs were fixed in 
paraformaldehyde, permeabilized with detergent and incubated with isoform-specific 
antibodies for 14-3-3, followed by application of a fluorescently-labeled secondary 
antibody and viewed by scanning confocal microscopy. The subcellular distributions of 
the isoforms were found to vary from one isoform to another. For example, 14-3-3ε is 
expressed uniformly throughout the oocyte with some peripheral accumulation, and 
absent in the interior of the egg cytoplasm (Figure 3E-F). Protein 14-3-3τ is distributed 
uniformly in oocytes and eggs, but is particularly absent along the inner nuclear 
membrane of all oocytes examined (Figure 3I-J). Isoforms 14-3-3β, 14-3-3γ and 14-3-3ζ 
exhibit a notable peripheral accumulation in oocytes, with a uniform distribution in eggs 
(Figure 3A-B, 3C-D and 3G-H respectively). Protein 14-3-3σ is found to be expressed in 
higher levels in nuclei of all oocytes studied, as compared to their cytoplasm, where it is 
uniformly dispersed with some accumulation selectively along one half of the cell (Figure 
3K); however, the 14-3-3σ isoform shows a uniform distribution in eggs (Figure 3L). 
Protein 14-3-3η is diffusely dispersed in oocyte with lesser distribution in the germinal 
vesicle than in the cytoplasm, but attains a uniform punctuate distribution with prominent 
accumulation in the region of the meiotic spindle in all eggs observed (Figure 3M-N). 
Control oocytes and eggs incubated in secondary antibody alone displayed little 
background fluorescence at the same laser intensities and confocal imaging settings used 
19 
 
 
 
for each immunofluorescence experiment (Figure 3O-P). No attempt was made to 
compare the relative fluorescence intensity of a particular isoform in oocytes or eggs with 
that of a different isoform, since the antibodies detecting the isoforms were all different. 
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Figure 3. Representative immunofluorescence images of 14-3-3 isoforms in oocytes 
and eggs isolated from adult mice. (A, B) 14-3-3β. (C, D) 14-3-3γ. (E, F) 14-3-3ε. (G, 
H) 14-3-3ζ. (I, J) 14-3-3 τ. (K, L) 14-3-3σ. (M, N) 14-3-3η. Confocal sections with 
regions of red fluorescence indicating the corresponding isoforms studied (see Methods). 
The inset in N shows the same egg labeled blue with Hoechst DNA stain (non-confocal 
image) and confirms that the darker areas in this region of the larger image are condensed 
metaphase II chromosomes. Control cells were included for each isoform experiment and 
were imaged using the same confocal settings. Representative control oocytes and eggs 
are shown in bright-field (O) and fluorescence (P). 14-3-3η accumulates, in part, in the 
meiotic spindle in eggs as shown by simultaneous labeling with 14-3-3η (Q) and tubulin 
(R) antibodies. These sequential scans are merged (14-3-3η + tubulin) in (S). The scale 
bars represent 10 μm for all images. 
 
These experiments are the first to examine all of the 14-3-3 proteins in mouse 
oocytes and eggs. Previous work suggested that multiple isoforms could be present, for 
example an examination of the maternal component of the zygotic polysomal mRNA 
population in mouse eggs and one-cell embryos revealed an increase in maternal mRNAs 
for 14-3-3β, 14-3-3γ, 14-3-3ζ, 14-3-3η and 14-3-3τ. The other isoform mRNAs were not 
examined in this paper [17]. 
It has been suggested that, in mammalian oocytes, 14-3-3 binds to and regulates 
the cell cycle control protein CDC25B phosphatase [11]. There is good evidence from 
studies of frog oocytes that 14-3-3 protein may act to hold the oocyte in prophase I arrest 
22 
 
 
 
by binding to and localizing phosphorylated CDC25B in the cytoplasm [18]. Following 
the induction of oocyte maturation, CDC25B is thought to be dephosphorylated and 
released from 14-3-3, allowing it to participate in the activation of MPF which leads to 
germinal vesicle breakdown and the resumption of meiosis. It is not known which of the 
seven isoforms in the mammalian oocyte might be interacting with CDC25B; it is shown 
here that all are present in oocytes. The interaction of 14-3-3 with the cell cycle control 
protein CDC25B has been examined in mammalian somatic cells. There is strong 
evidence to indicate that 14-3-3β, 14-3-3ε, and 14-3-3σ bind to CDC25B and that 14-3-
3β is responsible for sequestering CDC25B in the cytoplasm [11, 19]. Future experiments 
(chapter 3) determined if the other 14-3-3 isoforms, which have now been found to be 
present as well in mouse oocytes, also interact with CDC25B and whether they are 
involved in the regulation of oocyte maturation. 
Prominent localization of 14-3-3σ in the nuclei of oocytes (Figure 3I) is consistent 
with the observations that 14-3-3 proteins can shuttle through the nuclear membrane, but 
is in contrast with some observations in somatic cells in which it was noted that 14-3-3σ 
is more abundant in the cytoplasm than in the nucleus, while 14-3-3ζ is more abundant in 
the nucleus as compared to the cytoplasm [20]. 
Localization of 14-3-3η in the meiotic spindle (Figure 3N, Q, R and S) suggests a 
role for 14-3-3 in spindle assembly or cell cycle control. This is the first evidence for the 
localization of a specific 14-3-3 isoform in the metaphase II spindle of mouse eggs. It has 
been reported that 14-3-3ε and 14-3-3γ localize in the centrosome and mitotic spindle of 
some mouse somatic cells lines [21]. As detailed in chapter 4, additional functional 
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studies were performed to determine if 14-3-3η plays a role in the formation or regulation 
of the meiotic spindle or chromosome separation in mammalian oocytes. 
 
Expression of 14-3-3 isoforms in ovarian cells determined by immunohistochemistry 
As work on the role of 14-3-3 in ovarian development, oogenesis and cancer 
proceeds, it will be valuable to know which 14-3-3 isoforms are present and/or abundant 
in both the somatic cells and the germ cells within the ovary. Mouse ovarian follicular 
sections were examined by immunohistochemical staining using isoform-specific 
antibodies and the Avidin: Biotinylated enzyme Complex (ABC) technique. The sections 
contained ovarian follicles at all stages of development. The ABC method relies on the 
high affinity of avidin for biotin and the method is known to produce minimal 
background staining in the absence of primary antibody [22, 23]. Regions stained brown 
indicate presence of the 14-3-3 isoforms in contrast with regions counterstained blue. 
Again it is not possible to determine the relative amounts of distribution of a particular 
isoform in cells compared to other isoforms as the antibodies are different; nevertheless 
for a given isoform, variations in the intensities of staining indicate differences in relative 
amounts of expression among different cells in follicles and surrounding tissue. 
All seven isoforms of 14-3-3 protein were detected by immunohistochemistry, in 
cells of the ovary. Follicles at various stages of development exhibit some common 
features of expression of the isoforms. All isoforms of 14-3-3 were detected, to varying 
extents, in the oocyte and cumulus cells surrounding the oocyte, mural granulosa cells, 
theca interna and theca externa of all follicular stages examined, as well as in cells of the 
24 
 
 
 
corpus luteum (Figures 4, 5, 6, 7, 8, 9 and 10). In each of the follicular stages studied, all 
the isoforms appear to be expressed in the cytoplasm of the oocytes and to some extent in 
the corresponding germinal vesicles (Figures 4, 5, 6, 7, 8, 9 and 10). For all isoforms, 
staining appeared more intense in the cytoplasm than in the nuclei of somatic cells in 
granulosa and theca layers as well as in cells of corpora lutea (Figures 4, 5, 6, 7, 8, 9 and 
10). Cells within corpora lutea were also found to have relatively higher amounts of 
expression of all of the isoforms as compared to surrounding interstitial cells F in (F in 
Figures 4, 5, 6, 7, 8, 9 and 10). The isoform 14-3-3τ appears to be expressed at lower 
levels in somatic cells when compared to oocytes (Figure 9A-E). Atretic follicles, 
characterized by intensely stained pyknotic (apoptotic) and/or lytic cells, exhibit 
prominent accumulation of all isoforms of 14-3-3 (Figure 11A-G). Brain tissue sections 
were used as positive control for all isoforms of 14-3-3 except 14-3-3σ for which skin 
tissue was used as positive control as shown in Figure 13 (see methods).  
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Figure 4. Representative immunohistochemistry images of 14-3-3 β in the different 
stages of follicular development in ovarian sections. Brown staining represents 14-3-3 
β against regions counterstained blue with hematoxylin. (A) Primordial follicle. (B) 
Primary follicle. (C) Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced 
antral) follicle. (F) Corpus luteum. White arrows indicate the primordial or primary 
follicles in (A and B). Note the weaker staining in mural granulosa cells in secondary 
follicles (C, green arrows), the more intense stain along the zona pellucida of the oocyte 
(C, yellow arrow), and the more intense staining in cells lining the antral cavity (D and E, 
red arrows). The scale bars represent 10 μm (A-C) or 100 μm (D-F). 
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Figure 5. Representative immunohistochemistry images of 14-3-3 γ in the different 
stages of follicular development in ovarian sections. (A) Primordial follicle. (B) 
Primary follicle. (C) Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced 
antral) follicle. (F) Corpus luteum. White arrows indicate the primordial or primary 
follicles in (A and B). Note the weaker staining in mural granulosa cells in secondary 
follicles (C, green arrows) and the more intense staining in cells lining the antral cavity 
(D and E, red arrows). The scale bars represent 10 μm (A-C) or 100 μm (D-F). 
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Figure 6. Representative immunohistochemistry images of 14-3-3 ε in the different 
stages of follicular development in ovarian sections. (A) Primordial follicle. (B) 
Primary follicle. (C) Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced 
antral) follicle. (F) Corpus luteum. White arrows indicate the primordial or primary 
follicles in (A and B). Note the weaker staining in mural granulosa cells in secondary 
follicles (C, green arrows), the more intense stain along the zona pellucida of the oocyte 
(C, yellow arrow), and the more intense staining in cells lining the antral cavity (E, red 
arrows). The scale bars represent 10 μm (A-C) or 100 μm (D-F). 
 
28 
 
 
 
 
Figure 7. Representative immunohistochemistry images of 14-3-3 ζ in the different 
stages of follicular development in ovarian sections. (A) Primordial follicle. (B) 
Primary follicle. (C) Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced 
antral) follicle. (F) Corpus luteum. White arrows indicate the primordial or primary 
follicles in (A and B). Note the more intense staining in cells lining the antral cavity (E, 
red arrows). The scale bars represent 10 μm (A-C) or 100 μm (D-F). 
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Figure 8. Representative immunohistochemistry images of 14-3-3 η in the different 
stages of follicular development in ovarian sections. (A) Primordial follicle. (B) 
Primary follicle. (C) Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced 
antral) follicle. (F) Corpus luteum. White arrows indicate the primordial or primary 
follicles in (A and B). Note the weaker staining in mural granulosa cells in secondary 
follicles (C, green arrows) and the more intense staining in cells lining the antral cavity 
(E, red arrows). The scale bars represent 10 μm (A-C) or 100 μm (D-F). 
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Figure 9. Representative immunohistochemistry images of 14-3-3 τ in the different 
stages of follicular development in ovarian sections. (A) Primordial follicle. (B) 
Primary follicle. (C) Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced 
antral) follicle. (F) Corpus luteum. White arrows indicate the primordial or primary 
follicles in (A and B). Note the weaker staining in mural granulosa cells in secondary 
follicles (C, green arrows), the more intense stain along the zona pellucida of the oocyte 
(C, yellow arrow), and the more intense staining in cells lining the antral cavity (E, red 
arrows). The scale bars represent 10 μm (A-C) or 100 μm (D-F). 
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Figure 10. Representative immunohistochemistry images of 14-3-3 σ in the different 
stages of follicular development in ovarian sections. (A) Primordial follicle. (B) 
Primary follicle. (C) Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced 
antral) follicle. (F) Corpus luteum. White arrows indicate the primordial or primary 
follicles in (A and B). Note the weaker staining in mural granulosa cells in secondary 
follicles (C, green arrows), the more intense stain along the zona pellucida of the oocyte 
(C, yellow arrow), and the more intense staining in cells lining the antral cavity (D and E, 
red arrows). The scale bars represent 10 μm (A-C) or 100 μm (D-F). 
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Figure 11. Representative immunohistochemistry images of 14-3-3 protein isoforms 
in atretic follicles of adult mouse ovaries. (A) 14-3-3 β. (B) 14-3-3 γ. (C) 14-3-3 ε. (D) 
14-3-3 ζ. (E) 14-3-3η. (F) 14-3-3 τ. (G) 14-3-3 σ. All scale bars indicate 100 μm. 
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Figure 12. Representative control immunohistochemistry images for the different 
14-3-3 protein isoforms in tissue sections. (A) Example of a positive control brain 
section obtained for all 14-3-3 isoforms except for 14-3-3 σ. (B) Skin positive control for 
14-3-3 σ. (C) Example of a negative control section with no primary antibody obtained 
for all isoforms. (D) Example of a negative control with rabbit serum in place of primary 
antibody obtained for all isoforms. All scale bars indicate 100 μm. 
 
While the specific activities of 14-3-3 proteins in ovarian function are largely 
unknown, these proteins could play a significant role. For example, 14-3-3τ, shown to be 
present in human granulosa cells, has been shown to bind to the human follitropin 
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(follicle stimulating hormone, FSH) receptor suggesting a role for 14-3-3 proteins in 
follitropin signaling in granulosa cells [24, 25]. The reason for intense 14-3-3 staining in 
apoptotic cells is not known. 14-3-3 is generally associated with anti-apoptotic functions 
[26]. The 14-3-3 proteins appear to be involved in several ways in promoting cell 
survival; for example, 14-3-3 has been found to enhance the activity of proteins with 
proliferative or survival roles, such as members of the Raf family, while antagonizing the 
activity of proteins that promote cell death [3, 27]. There is some suggestion that 14-3-3σ 
is associated with the survival of granulosa cells and inhibition of 14-3-3 interaction with 
target proteins, without regard to isoform, promotes apoptosis in these cells [28, 29]. 
Several characteristic differences in expression of 14-3-3 protein isoforms in 
different stages of follicular development were observed by immunohistochemical 
staining. Detection of 14-3-3β, 14-3-3γ, 14-3-3ε, 14-3-3τ and 14-3-3σ in zonae pellucidae 
of oocytes by immunohistochemical staining indicates secretion of some 14-3-3 proteins 
into the zonae and perivitelline space (Table 1; C in Figures 4, 6, 9 and 10). To examine 
this by another method, zona-intact oocytes were isolated and viewed by 
immunofluorescence. Such immunocytochemical staining detected the same isoforms 
along the membranes of the isolated oocytes and within or along the zonae pellucidae of 
oocytes (Figure 12B, D, F, L and N), indicating secretion of those 14-3-3 isoforms by the 
oocyte or associated follicle cells. Control oocytes processed for fluorescence microscopy 
without the addition of primary antibody showed minimal or no background fluorescence 
(Figure 12O-P). 
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Table 1. Characteristic differences in expression of 14-3-3 protein isoforms in the 
different stages of follicular development as observed by immunohistochemical 
staining of adult mouse ovarian sections. 
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Figure 13. Representative immunocytochemistry images of 14-3-3 protein isoforms 
along and in the zonae pellucidae of cumulus-free oocytes isolated from ovaries of 
adult mice. The zona-intact cells were fixed in paraformaldehyde but not treated with 
detergent (see Methods). Paired images of an oocyte (left image is brightfield and right is 
immunofluorescence) indicate staining along the zona and/or the cell membrane for all 
isoforms except 14-3-3ζ. Note: the intent of this part of the study was not to examine the 
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intracellular distribution of the isoforms (see Figure 3 for those experiments) since the 
cells were not permeabilized to permit complete antibody penetration; however, cells 
may be partially permeabilized by fixation accounting for the detection of intracellular 
proteins in some cells. (A, B) 14-3-3β. (C, D) 14-3-3γ. (E, F) 14-3-3ε. (G, H) 14-3-3ζ. (I, 
J) 14-3-3η. (K, L) 14-3-3τ. (M, N) 14-3-3σ. (O, P) Control image without primary 
antibody addition. 
 
The function, if any, of extracellular 14-3-3 surrounding the oocyte is not yet 
known. This was not believed to be an artifact of fixation since the appearance of the 
extracellular 14-3-3 was found by two different methods and the absence of staining for 
some isoforms argues against nonspecific artifacts. No extracellular 14-3-3 proteins were 
found to be associated with mature, ovulated eggs, which also suggests that this is not an 
artifact (data not shown). While the 14-3-3 proteins are generally known as intracellular 
proteins, some 14-3-3 proteins are known to be secreted by somatic cells; for example, it 
has been known for some time that 14-3-3 proteins are found in the cerebrospinal fluid 
[30] where they may serve as markers for Creutzfeldt-Jakob disease. Keratinocytes 
secrete 14-3-3σ which induces expression of matrix metalloproteinase 1 (MMP1 or 
collagenase) in fibroblasts [31]. Three isoforms, 14-3-3 σ, 14-3-3 γ and 14-3-3ζ, are 
secreted by corneal epithelial cells and ocular cell lines [32]. The 14-3-3ζ protein is 
secreted by certain tumor-associated inflammatory cells [33]. 
Another notable difference in the distribution of 14-3-3 isoforms in ovarian 
folliculogenesis is prominent lack of expression 14-3-3β, 14-3-3γ, 14-3-3ε, 14-3-3τ, 14-3-
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3η and 14-3-3σ in the peripheral mural granulosa cells, as compared to other cells of 
secondary, early antral and/or Graafian follicles (Table 1; C in Figures 4, 5 and 6 and 8, 9 
and 10). At early antral stages, intense staining was noted for 14-3-3β, 14-3-3γ and 14-3-
3σ in granulosa cells surrounding the antrum (Table 1; D in Figures 1, 2 and 10). At the 
Graafian stage, all isoforms appear to accumulate in these cells (Table 1; E in Figures 4, 
5, 6, 7, 8, 9 and 10). 
 
 
Materials and Methods 
 
Collection of Oocytes and Eggs and Preparation of Ovarian Tissue Extracts 
All mice used in the present experiments were housed and used at Kent State 
University under an approved Institutional Animal Care and Use Committee protocol 
following the National Research Council's publication Guide for the Care and Use of 
Laboratory Animals. Oocytes and eggs were collected as previously described [12]. CD1 
mice (2.5 months old) were injected with 7.5 IU eCG and, 44-48 hours later, the ovaries 
were removed and repeatedly punctured with a 26-gauge needle to rupture follicles. 
Cumulus cell-enclosed oocytes were isolated and the cumulus cells were removed by 
repeated pipetting though a small-bore pipette. Fully-grown oocytes with intact nuclei 
(germinal vesicles) were cultured in MEM containing 0.1 mg/ml dibutyryl cAMP to 
prevent spontaneous oocyte maturation. Mature, metaphase II-arrested eggs were 
obtained from mice 13-14 h following superovulation by injection of 7.5 IU hCG which 
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was preceded by a priming injection of 7.5 IU eCG injection 48 h earlier. The cumulus 
cells were removed with 0.3 mg/ml hyaluronidase. Zonae pellucidae from oocytes and 
eggs thus collected were removed by a brief treatment in acid Tyrode's solution (0.14 M 
NaCl, 3 mM KCl, 1.6 mM CaCl2.2H2O, 0.5 mM MgCl2.6H2O, 5.5 mM glucose, and 
0.1% PVA, pH 2.5). Cells were rinsed in MEM and prepared for use in Western blot or 
immunocytochemistry as described below. 
Ovaries from unprimed adult mice (2.5 months old), along with brain tissues, 
were homogenized in a buffer containing (10 mM Tris pH 7.0, 1 mM EDTA, 1 mM 
EGTA, 0.16% benzamidine hydrochloride, 14 mM beta-mercaptoethanol, 1 mM PMSF 
and 0.1 mM TPCK) pH 7.2, using a mechanical homogenizer. The homogenized cell 
lysates were then centrifuged at 16,000 g for 30 minutes and the supernatants containing 
the total soluble protein extracts were used for SDS-PAGE and Western blotting. 
 
SDS-PAGE, Western Blotting and Protein Analysis 
The 14-3-3 isoforms were identified through multiple Western blots (using 
standard Western blotting procedures), each testing for one of the seven isoforms in 
protein extracts. Oocytes and eggs were rinsed in MEM, counted, and transferred to Tris-
buffered saline (TBS; 25 mM Tris-HCl [pH 7.5] and 150 mM NaCl) containing 0.1% 
PVA. Cells were removed from the TBS, lysing buffer was added, and the cell lysates 
were quick-frozen in ethanol/dry ice and stored at -70°C until use. The lysis buffer 
contained 10 mM Tris-HCl [pH 7.2], 1 mM EDTA, 1 mM EGTA, 0.1% (v/v) b-
mercaptoethanol, 1% (v/v) Triton X-100, protease inhibitors (1 mM PMSF, 0.1 mM 
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TPCK, 10 μM leupeptin, 1 μM pepstatin A, and 75 nM aprotinin), and phosphatase 
inhibitors (1 mM Na3VO4, 100 nM calyculin A, 10 mM beta-glycerophosphate, and 5 
mM sodium pyrophosphate). 
Proteins from the lysates of 200 oocytes or 200 eggs were separated by SDS-
PAGE using a 4% stacking, 12% resolving polyacrylamide gel and electrophoretically 
transferred to Immobilon-P PVDF membrane (Millipore Corp.). The membranes were 
incubated in blocking buffer (5% milk in TBS, 0.1% Tween-20) and then with primary 
antibodies overnight at 4°C, washed and incubated with secondary antibody and imaged 
by chemiluminescence with an enhanced chemiluminescence kit according to the 
manufacturer's instructions (GE Healthcare Life Sciences) using the Fujifilm LAS-3000 
luminescent image analyzer. Protein extracts of ovaries from adult mice were included 
for comparison among immunoblots for all 14-3-3 isoforms. Brain extract was used as a 
positive control for detecting all isoforms of 14-3-3 except 14-3-3σ for which skin extract 
was used as positive control. This is because all isoforms of 14-3-3 have been identified 
in brain except 14-3-3σ which has been detected in skin [15].  
The commercial rabbit anti-14-3-3 isoform panel (PAN017) from AbD Serotec 
was used for Western blotting as well as immunocytochemical and immunohistochemical 
staining (see below) of the different 14-3-3 isoforms in mouse ovaries, oocytes and eggs. 
The immunogens, against which the antibodies were raised, were synthetic peptides 
corresponding to acetylated N-terminal sequences of sheep 14-3-3 proteins. They are 
raised against synthetic peptides corresponding to the following acetylated N-terminal 
sequences of sheep 14-3-3 isoforms: 14-3-3β, TMDKSELVC; 14-3-3γ, 
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VDREQLVQKAC; 14-3-3ε, MDDREDLVYQAKC; 14-3-3ζ: MDKNELVQKAC; 14-3-
3η, GDREQLLQRARC; 14-3-3 τ, MEKTELIQKAC; 14-3-3σ, MERASLIQKAC. 
Two additional antibodies to 14-3-3β and 14-3-3ζ were also used to confirm the 
presence of these isoforms (rabbit anti-14-3-3β, sc-628 and rabbit anti-14-3-3 ζ sc-1019, 
Santa Cruz Biotechnology). All antibodies were used at a dilution of 1:1,000 in blocking 
buffer (5% milk in 1X TBS, 0.1% Tween-20). The secondary antibody for all 
experiments was HRP-conjugated goat anti-rabbit (Genscript; 1 mg/ml stock) used at a 
dilution of 1:2,000 in the blocking buffer. 
The relative abundance of each 14-3-3 isoform in oocytes and eggs was 
determined in a semi-quantitative manner. Proteins from 200 oocytes and 200 eggs were 
separated by electrophoresis on the same gel, transferred to membrane at the same time 
and immunoblotted together under the same conditions using one of the six 14-3-3 
antibodies. This procedure was repeated two additional times with the same antibody. 
There will be inherent differences in the intensities of bands for each immunoblot 
processed, but for a given blot the intensity of the egg band can be compared to the 
intensity of the oocyte band. To summarize the three experiments for each of the six 
isoforms, the band intensities for oocyte and egg lanes in a given blot were analyzed 
using NIH image and compared to each other. The intensity of the oocyte band was 
normalized to 100% for each blot and the egg intensity (reflecting the relative protein 
amount) was then expressed as a percentage of the oocyte intensity for each of the three 
blots analyzed for each isoform. Note that no comparison should be drawn for the band 
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intensities among the isoforms since the antibodies detecting the isoforms were different 
from each other, with possible differences in their affinities. 
 
Immunocytochemistry of oocytes and eggs 
Oocytes and eggs were fixed in freshly prepared 3.7% paraformaldehyde for 30-
60 min, washed in PBS-PVA (PBS containing 1% PVA), permeabilized with 1% Triton 
X-100 to promote antibody penetration, washed in PBS-PVA, then treated with blocking 
buffer (5% normal goat serum in PBS-PVA), and incubated overnight with each of the 
primary antibodies for 14-3-3 isoforms (rabbit anti-14-3-3 isoform panel PAN017, AbD 
Serotec; diluted 1:200 in 1% goat serum blocking buffer). Following washing, the cells 
were incubated with Cy3-conjugated goat anti-rabbit secondary antibody (Jackson 
ImmunoResearch Laboratories) diluted 1:200 in blocking buffer for several hours, 
washed again and transferred to an anti-fade solution (SlowFade; Invitrogen). All cells 
were imaged with the Olympus Fluoview FV500 confocal microscopy system using a 
60× oil immersion lens and various confocal zooms; the scale bars on the images indicate 
the final magnification. Images were captured and examined at multiple confocal planes. 
The representative images shown here are primarily images at the plane of the optical 
equator. For each isoform experiment, 5-7 oocytes and 5-7 eggs were examined at the 
same time under the same staining and imaging conditions. The experiment was repeated 
twice for each isoform. 
In oocytes, the nucleus is readily discernible in fluorescence images or the 
corresponding bright field images. In eggs, the location of the condensed metaphase II 
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chromosomes can sometimes be determined by a bulge at one pole of the egg or by the 
absence of fluorescence causing an outline of the unlabeled chromosomes. In an 
additional experiment using the 14-3-3η antibody, condensed meiotic chromosomes in 
eggs were identified by staining with the DNA-staining Hoechst dye (0.001 mg/ml) and 
imaged with conventional epifluorescence microscopy (Figure 3N, inset). In several 
experiments, eggs were simultaneously incubated in both the 14-3-3η isoform antibody 
and an antibody to α-tubulin to identify the meiotic spindle microtubules (rat anti-α 
tubulin; sc-69970; 200 μg/ml diluted 1:200 in 1% blocking buffer; Santa Cruz 
Biotechnology). The secondary antibody was FITC-conjugated goat anti-rat from 
(Jackson Laboratories) (diluted 1:200 in blocking buffer). In all cases, control oocytes 
and eggs were incubated in secondary antibody alone and imaged using the same 
confocal settings as used for experimental, antibody-labeled cells. Background 
fluorescence was minimal. 
An additional set of immunofluorescence experiments was performed to examine 
the presence of extracellular 14-3-3 isoforms associated with isolated oocytes. The 
immunofluorescence method was used as described above, but with several changes. In 
this case, the zonae were not removed before fixation in 3.7% paraformaldehyde and the 
cells were not treated Triton X-100 to permeabilize the cell membranes following 
fixation. All other staining procedures were the same. I wanted to look at the possibility 
of secreted proteins in oocytes. This experiment was not intended to examine the 
intracellular distribution of isoforms (see above methods and Figure 3 for that 
experiment); however, it is known for many years that mouse oocytes and eggs 
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sometimes are partially permeabilized on fixation alone (no detergent added). Therefore 
some staining within the oocytes may occur, but is not be a complete representation since 
the permeability of cells may vary from cell to cell and is not uniform within a cell. 
 
Immunohistochemistry of tissue sections 
Ovaries, brain and skin tissues were collected from unprimed adult mice (2.5 
months old) and fixed in 4% paraformaldehyde in PBS overnight. They were then 
dehydrated through a graded series of ethanol followed by two changes of CitriSolv and 
embedded in paraffin. Multiple microtome tissue sections of 6 μm thickness were 
transferred to slides pre-coated with poly-L-lysine. Following removal of paraffin and 
rehydration, antigens were recovered by boiling the sections for 1 min, three times in 
Antigen Retrieval Citra solution (#HK086-5K, Biogenex) with intermittent cooling. 
Tissue sections were then cooled at room temperature for 30 min and then washed in 
deionised water for 5 min. Endogenous peroxidase was blocked by incubation of tissue 
sections in 0.3% hydrogen peroxide for 30 min. Tissues were then incubated for 20 min 
in PBS blocking buffer with 0.15% normal goat serum (VectaStain Elite ABC Kit, #PK-
6101, Vector Laboratories). Tissues sections were incubated overnight at 4°C in a 
humidified chamber with each of the different primary antibodies (14-3-3 isoform panel 
PAN017, AbD Serotec, see above) diluted in blocking buffer at dilutions recommended 
by the manufacturer and a prior study [34]:14-3-3β 1:600, 14-3-3γ 1:800, 14-3-3ε 1:400, 
14-3-3ζ 1:400, 14-3-3η 1:3,200, 14-3-3τ 1:60, and 14-3-3σ 1:100. The same dilutions 
were used for positive control sections. The rabbit serum used in matching negative 
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control sections, were immunostained at a dilution identical to that used in corresponding 
sample sections for the isoforms. 
Following antibody incubation, slides containing tissue sections were washed in 
buffer (PBS, pH 7.5) for 5 min, incubated for 30 min in biotinylated secondary antibody 
(VectaStain Elite ABC Kit, Vector Laboratories) diluted in blocking buffer and washed 
again in buffer for 5 minutes. This was followed by incubation of the tissues for 30 min 
in VectaStain Elite ABC Reagent (prepared according to the manufacturer's instructions; 
Vector Laboratories). DAB substrate was prepared using Vector Laboratories DAB 
peroxidase substrate Kit (SK-4100) according to instructions specified in kit. Tissues 
were treated with DAB substrate for 3-4 minutes until development of optimum brown 
color, rinsed with tap water and counter-stained with Hematoxylin. 
The ABC-immunostaining method produces minimal background staining. To 
examine the background staining, two sets of negative controls were used. One set of 
tissue sections was processed without the addition of primary antibodies. Since the 
primary antibodies were rabbit polyclonals, the other control set utilized tissue sections 
incubated in normal rabbit serum (Jackson ImmunoResearch) prior to incubation with the 
secondary antibodies. In both cases, control sections did not show brown staining, 
confirming specific localization by this method. Brain tissue sections were used as 
positive control for all isoforms of 14-3-3 except 14-3-3σ for which skin tissue was used 
as positive control (see Figure 13). This is because all isoforms of 14-3-3 have been 
identified in brain with the exception of 14-3-3σ [13]. Skin sections were used as positive 
control for 14-3-3σ since 14-3-3σ is known to be found in epidermis [15] (see Figure 13). 
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For each isoform, dilutions of primary antibodies or rabbit serum for positive and 
negative controls were kept identical. Each 14-3-3 isoform was studied individually in a 
set of three separately stained ovarian tissue sections, along with simultaneous staining of 
appropriate positive and negative controls. In addition the studies were repeated on 
sections obtained from the ovary of a different unprimed adult mouse of the same age. 
The characteristic features for all 14-3-3 isoforms, as identified by immunohistochemical 
staining, were examined and tabulated (Table 1) independently by three individuals with 
agreement on the observations. 
 
Conclusions 
The work shows, for the first time, the expression of all seven mammalian 
isoforms of the protein 14-3-3 in the female mouse germ cells and in cells of mouse 
ovarian follicles at various stages of development. There are characteristic differences in 
the relative amount and distribution of 14-3-3 proteins in oocytes and eggs. Protein 14-3-
3η, for example localizes, in part, to the meiotic spindle in eggs. A number of isoforms 
appear to be extracellular and associated with the zona pellucidae in ovarian oocytes. The 
distribution of some 14-3-3 isoforms within cells of the ovary differs, for example with 
peripheral mural granulosa cells expressing some isoforms and not others. All 14-3-3 
isoforms appear to be present in relatively greater amounts in cells lining the antral cavity 
of Graafian follicles and in granulosa cells of atretic follicles. These results will enable 
further research investigating 14-3-3 interactions with other key proteins involved in 
ovarian development and gamete function. 
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CHAPTER 3 
Investigation of isoform-specific interactions 
of 14-3-3 (YWHA) proteins  
with CDC25B phosphatase  
in regulating mouse oocyte maturation 
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Background 
 
Within the mammalian ovary, the oocyte is held in first meiotic prophase. At 
puberty, oocytes in pre-ovulatory follicles resume meiosis in response to luteinizing 
hormone (LH). Release from meiotic arrest and production of a mature, fertilizable egg is 
dependent on the activation of maturation promoting factor (MPF; outlined in Figure 1), a 
complex of cyclin-dependent kinase 1 (CDK1) and the regulatory cyclin B1 (CCNB1) 
reviewed in [1].  MPF is well characterized, based on studies of amphibian and 
mammalian oocytes as well as somatic cells since it is the cell cycle regulatory factor for 
both meiotic and mitotic cells [2-4]. The phosphorylation status of CDK1 (and thus its 
activity) is regulated by protein kinases and phosphatases controlled by signaling 
molecules produced in the oocyte and surrounding somatic cells.  In the arrested state of 
prophase I in mouse oocytes, MPF is inactive due to phosphorylation of CDK1 through 
the activity of WEE1/MYT family of kinases including the oocyte-specific WEE2 [5-8]. 
Evidence indicates that the cAMP dependent protein kinase, PKA maintains meiotic 
arrest in mouse oocytes by phosphorylating WEE2 (also known as WEE1B) [7].  In 
addition, PKA is thought to phosphorylate CDC25 proteins [9, 10], which keeps CDC25 
proteins in an inactive state that preserves the phosphorylated and inactive status of 
CDK1.    
In mouse oocytes, constitutively active heterotrimeric G protein-coupled 
receptors, linked to stimulatory G proteins (Gs), activate adenylyl cyclase that maintains 
a high concentration of cAMP and PKA activity within the oocyte [11-16].  The 
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concentration of cAMP is controlled by the Gs-adenylyl cyclase responsible for the 
generation of cAMP and also by the activity of cAMP phosphodiesterases that degrade 
the phospodiester bond in cAMP to inactivate it, and thus regulate the duration and 
amplitude of the cAMP signal.  It has been reported that oocytes deficient in 
phosphodiesterase 3A (PDE3A) do not degrade cAMP and thus cAMP accumulates and 
meiotic arrest persists [17]. 
Recent research indicates that the high level of cAMP in the follicle-enclosed 
oocyte is sustained by cGMP produced in somatic cells which passes through gap 
junctions and inhibits the hydrolysis of cAMP by PDE3A [18]. Luteinizing hormone 
(LH) is thought to interrupt the flow of inhibitory cGMP in part by rapidly and 
completely causing the closure of gap junctions between somatic cells in the follicle [19, 
20]. With reduced cAMP levels and PKA activity, MPF is activated by reduced 
phosphorylation of WEE1/MYT family of kinases and the dephosphorylation of CDK1 
by CDC25 proteins [21-23].  Activation of maturation promoting factor (MPF) initiates 
the resumption of meiosis and the process of oocyte maturation beginning with nuclear 
envelope breakdown (germinal vesicle breakdown) followed by formation of the first 
polar body and, in most mammals, arrest at metaphase of the second meiotic division, 
reviewed in [24, 25]. Failure of oocyte maturation has been documented in animal 
models and must be considered when human female infertility is examined [26].  Oocyte 
maturation forms the mature egg and fertilization releases the egg from metaphase II 
arrest, allowing formation and development of the zygote. 
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Figure 1. Simplified diagram of the key proteins involved in oocyte arrest at 
prophase I (left) and the release from meiotic arrest (right).  In the arrested state, 
Mitosis Promoting Factor (MPF), composed of Cyclin-Dependent Kinase 1 (CDK1) and 
Cyclin B (CYB), is inactive because of phosphorylation on CDK1 (-P).  The phosphatase 
CDC25B is phosphorylated (by PKA or perhaps another kinase dependent on PKA), 
bound to 14-3-3, and thereby rendered inactive. As cAMP levels fall (triggered by the 
pre-ovulatory surge in luteinizing hormone in vivo or removal of the oocyte from the 
ovary), CDC25B is dephosphorylated, perhaps by protein phosphatase 1 (PP1), and is 
released from 14-3-3. Active CDC25B then dephosphorylates CDK1.  MPF becomes 
active and the oocyte is released from meiotic arrest. This model is based in part on 
studies of frog oocyte maturation. 
 
In mouse oocytes, genetic studies have shown that CDC25B is the primary 
phosphatase regulating the dephosphorylation of CDK1 and not CDC25C [27, 28] 
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although CDC25A also appears to play a role in oocyte maturation [29].  CDC25B is 
inactivated by phosphorylation by PKA and probably is dephosphorylated by protein 
phosphatase 1 (PP1) and/or protein phosphatase 2 (PP2) reviewed in [30].  Thus, the 
release from meiotic arrest in the oocyte is dependent on the activation of activation of 
CDC25B by dephosphorylation.  In addition, CDC25B is presumed to be bound to the 
cell cycle regulatory protein 14-3-3 (YWHA or Tyrosine 3-Monooxygenase/Tryptophan 
5-Monooxygenase Activation protein) which is assumed to both maintain the 
phosphorylated status of CDC25 and sequester CDC25 in the oocyte cytoplasm. Previous 
studies show that in Xenopus oocytes, CDC25 phosphatase is phosphorylated by PKA, 
and is bound to and sequestered by 14-3-3 in the cytoplasm [31],  thus preventing 
germinal vesicle breakdown and maturation of oocytes. A number of studies implicate 
14-3-3 as a critical regulator of the cell cycle in meiotic and mitotic cells [32-39].  
Proteins of the 14-3-3 (YWHA) family are now known to be central mediators in 
a variety of cellular signaling pathways involved in development and growth including 
cell cycle regulation and apoptosis [40-44]. The 14-3-3 is a highly conserved, 
homologous family of proteins that have been shown to bind to various cellular proteins 
where they have been found to complement or supplement intracellular events involving 
phosphorylation-dependent switching or protein-protein interaction [42, 45]. Generally 
(but not exclusively), 14-3-3 binds to amino acid motifs in target proteins that contain a 
phosphorylated serine residue and an arginine residue at positions -3 or -4 (i.e. 
ArgXXpSer or ArgXXXpSer, where Arg is arginine, pSer is a phosphorylated serine and 
X is any amino acid) [46, 47]. Most of the binding partners of 14-3-3 are phosphorylated; 
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however, phosphorylation-dependent sites that differ significantly from these motifs have 
been reported [48], and some interactions of 14-3-3 do exist independent of 
phosphorylation. The 14-3-3 proteins exist mainly as homo- or hetero-dimers with a 
monomeric molecular mass of approximately 30 kDa [40].  There are seven mammalian 
isoforms of 14-3-3 encoded by separate genes. We previously found that all seven 
mammalian isoforms of 14-3-3 are expressed in mouse ovaries, immature oocytes and 
mature eggs [49]. It is known that different isoforms of 14-3-3 can interact with the same 
ligand and so are somewhat interchangeable, however, although isoforms of 14-3-3 often 
bind the same protein, there are some indications that homodimers of different types or 
even heterodimers of 14-3-3 may have different roles in the regulation or sequestering of 
proteins [48, 50].  Therefore, I explored the interactions of all seven 14-3-3 isoforms with 
CDC25B to identify which of the 14-3-3 proteins is/are involved in regulating CDC25B 
and meiotic arrest in mouse oocytes.  
This chapter shows the results using the in situ proximity ligation assay (PLA; 
Figure 2) along with co-immunoprecipitation experiments to examine the molecular 
interactions between each of the 14-3-3 isoforms and CDC25B.  The PLA method has 
been used successfully to not only detect protein-protein interactions at the single 
molecule level directly in cells, but also to visualize the actual intracellular sites of the 
interactions in different types of cells and tissues [51-54].  In the PLA method, specific 
primary antibodies (raised in different species) bind to target proteins.  A pair of unique 
oligonucleotide-conjugated secondary antibodies (PLA probes) bind to the primary 
antibodies and when the PLA probes are in close proximity (<40 nm), the DNA strands 
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are joined by enzymatic ligation.  A circular DNA molecule is generated and then 
amplified by rolling circle amplification.  The original in situ protein-protein interaction 
is revealed by the amplified DNA through hybridization of a fluorescent probe.  The PLA 
technique is sensitive, specific, and provides a high signal to noise ratio because the 
signal is amplified and close proximity of the target proteins is required.  Thus, the 
method permits detection of two proteins that interact at the molecular level.  
 
Figure 2. Schematic representation of the process of in situ Proximity Ligation 
Assay to detect interaction between two proteins. Shown here is the method to identify 
the sites of interaction of 14-3-3 proteins with CDC25B phosphatase, using respective 
primary antibodies raised in different species. Figure courtesy: Olink Bioscience.  
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To investigate which of the 14-3-3 isoforms is/are central in regulating CDC25B-
mediated CDK1 activation and oocyte maturation, experiments were performed to reduce 
the activity or expression of 14-3-3 proteins in mouse oocytes by intracellular 
microinjection of a translation-blocking morpholino oligonucleotide against each of the 
14-3-3 isoform mRNAs.  Morpholino oligomers are small sequences of synthetic 
nucleotides consisting of about 25 standard nucleic acid bases attached to morpholine 
rings (rather than ribose rings) with a phosphorodiamidate non-ionic linkage instead of a 
phoshodiester linkage (giving the oligonucleotide a net neutral charge).  With the 
appropriate experimental controls [55], morpholinos have a number of advantages 
including specificity resistance to nucleases.  Morpholinos appear to have few off-target 
interactions and little non-antisense activity because they are specific (binding to at least 
13-14 contiguous bases) and the neutral charge gives little interaction with other RNA 
species or cellular proteins [56, 57].  Experiments utilizing morpholino antisense 
oligomers have implicated functions of a number of proteins in mouse oocyte meiotic 
maturation [58-67].   
The experiments outlined in this report give information about the interactions of 
14-3-3 isoforms with CDC25B and provide support to the model shown in Figure 1 
where release from meiotic arrest with falling cAMP and reduced PKA activity results in 
dephosphorylation of CDC25B and its uncoupling from 14-3-3, permitting the CDC25B 
to activate MPF and promote oocyte maturation.  
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Results and Discussion 
 
CDC25B distribution during mouse oocyte maturation  
As shown by other investigators, it was observed that CDC25B translocates into 
and accumulates in the oocyte nucleus following release from meiotic arrest (Figure 3A-
E).  In these experiments CDC25B was labeled with an antibody generated in rabbit 
against human CDC25B, which is known to react with mouse CDC25B.  Confocal 
imaging reveals that CDC25B is distributed throughout the prophase I-arrested oocyte 
cytoplasm and that some CDC25B is also present within the nucleus (Figure 3A).  During 
the initial stage of oocyte maturation CDC25B accumulates in the nucleus and by 2 hours 
after release from meiotic arrest the concentration of CDC25B is much greater in the 
region where the germinal vesicle (nucleus) had broken down, as shown in Figure 3B-D.  
In all oocytes studied, at each of the time points, the identical distribution of CDC25B 
was noted.  Minimal background staining was observed in all of three control oocytes 
processed simultaneously and imaged at the same confocal settings, but without the 
primary antibody (Figure 3E).  The following experiments used an antibody raised in 
goat against a peptide mapping at the N-terminus of CDC25B of human origin, which 
reacts also with mouse CDC25B in mouse.   As shown later, there is some evidence that 
these two antibodies label the same protein.  
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Figure 3. Representative indirect immunofluorescence images showing intracellular 
distribution of CDC25B during mouse oocyte maturation. Paired confocal images (A-
D) of equatorial sections through oocytes (left: immunofuorescence; right: bright field) 
indicate gradual localization of CDC25B phosphatase into the germinal vesicle along a 2-
hour time course assay during in vitro maturation of mouse oocytes.  Control oocytes 
processed simultaneously in absence of the primary antibody showed minimal 
background fluorescence (E). Scale bars represent 10 μm.  
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In Situ Proximity Ligation Assays (PLA) reveal interactions between CDC25B and 
all 14-3-3 isoforms in mouse oocytes, with reduced interactions in eggs 
To determine the possible binding of each of the 14-3-3 isoforms with CDC25B, a 
series of in situ proximity ligation assays was performed to identify interactions of the 
two proteins at the molecular level. Following primary antibodies binding to 14-3-3 and 
to CDC25B, when the PLA secondary probes are in close proximity (<40 nm), as would 
be expected for two proteins that are interacting with each other, the oligonucleotide 
DNA chains cross-link with each other when hybridized with connector oligos, forming 
circular DNA which is amplified and detected by a fluorescent probe highlighting the 
reaction site as a distinct, bright fluorescent dot when viewed by fluorescence 
microscopy.  We previously examined the 14-3-3 isoforms in oocyte and egg extracts by 
Western blotting after polyacrylamide gel electrophoresis and by indirect 
immunofluorescence as well as immunohistochemical staining of cells within ovarian 
sections [49]. All three approaches relied on a panel of antibodies that has been shown to 
be specific for the various 14-3-3 isoforms [68-70].  As shown below, the goat CDC25B 
antibody used in these experiments is specific as evidenced by Western blots, and by its 
co-localization with a rabbit CDC25B antibody (directed at a different epitope) as well as 
with a phospho-specific anti-mouse CDC25B antibody.   
The PLA assay revealed interactions of all seven 14-3-3 protein isoforms with 
CDC25B within oocytes and eggs using primary antibodies directed at each of the 14-3-3 
isoforms and CDC25B.  Representative equatorial as well as compressed z-stack images 
of oocytes and eggs from PLA assays are provided in Figure 4 and Figure 5.  Figure 4A-
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C show representative images of the interaction of 14-3-3β and CDC25B in a mouse 
oocyte.  Interactions are visible in a single equatorial scan (Figure 4A).  Each cell was 
scanned at 3 µm intervals throughout the cell.  An abundance of interaction sites is 
visualized when these scans are compressed to one image (Figure 4B). The typical 
number of interaction sites counted in these oocytes in a single experiment, range from 
116 to 289, in seven different oocytes examined.  It should be noted that the PLA method 
does not show the complete distribution of all CDC25B and 14-3-3 proteins as would be 
shown in conventional immunofluorescence but does show protein-protein interactions 
when a number of criteria have been met that include binding of the two primary 
antibodies, binding of secondary probes, ligation, amplification and binding of 
fluorescent detection probes.  Each of these steps is concentration- and time- dependent. 
The number of fluorescent spots represents only a portion of the protein-protein 
interactions but this method clearly provides more information than simple co-
localization studies with immunofluorescence microscopy. 
Representative images of the interactions of 14-3-3β with CDC25B in a mouse 
egg are shown in Figure 4D-F.  The number of interaction sites is reduced in mature eggs 
compared to immature oocytes.   In each of two independent experiments performed to 
detect interaction of each 14-3-3β isoform with CDC25B, both oocytes and eggs were 
examined at the same time under the same conditions of reagent concentration, 
temperature, incubation times and imaging conditions. The average per cent in situ PLA 
sites of interaction between 14-3-3β and CDC25B in eggs was reduced by 52% compared 
to those in oocytes.  
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Neither of six control oocytes and six control eggs treated simultaneously and 
under identical conditions, incubated either with no primary antibodies (Figure 4G-L), or 
with goat anti-CDC25B primary antibody alone, or with rabbit anti-14-3-3β primary 
antibody alone, displayed any PLA reaction spot.  Background fluorescence from 
unbound fluorescent DNA probes was minimal. To confirm the effectiveness of the PLA 
method by another experiment, oocytes were processed for PLA using two different 
antibodies to CDC25B, one made in the rabbit and the other in goat, each of which bind 
to CDC25B in mouse oocytes.  With these two antibodies, in situ PLA reaction spots 
were detected in all of three different oocytes examined, as shown in Figure 4M-O.  
Detection of  the PLA reaction spots clearly supports the PLA method as these two 
antibodies bind to the same protein which are certainly within 40 nm to support the 
process of secondary probe DNA ligation and amplication. In this experiment as well, all 
of three control oocytes processed simultaneously in the absence of primary antibodies 
showed no PLA reaction site and minimal background fluorescence from any 
unhybridized detection probe (Figure 4P-R).   
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Figure 4. Representative oocytes and eggs showing PLA reaction spots for 
interaction of 14-3-3β with CDC25B, compared to controls. Shown are an oocyte (A-
C, G-I, M-O, P-R) and an egg (bottom panel; D-F, J-L) imaged at an equatorial plane of a 
single confocal scan (A, D, G, J, M, P), a compressed z stack of all confocal scans 
throughout the cells (B, E, H, K, N, Q) and bright field image (C, F, I, L, O, R). Bright, 
fluorescent PLA reaction spots indicating sites of interaction of 14-3-3β with CDC25B 
were noted throughout cytoplasm and germinal vesicle of oocytes (A-C), with reduced 
interaction sites in eggs (D-F). No PLA reaction spot was observed in control oocytes (G-
I) and control eggs (J-L) processed simultaneously in absence of primary antibodies. PLA 
using two primary antibodies against CDC25B detected the protein in experimental 
oocytes (M-O), but no PLA reaction spot was noted in control oocytes processed in 
absence of the primary antibodies, and background fluorescence was minimal (P-R). 
Scale bars represent 10 μm.  
 
In addition to interation of 14-3-3β with CDC25B as shown above, the PLA 
method revealed that the other six 14-3-3 isoforms also interact with CDC25B in oocytes, 
with reduced interactions in eggs (Figure 5).    
67 
 
 
 
 
Figure 5. Representative oocytes and eggs showing PLA reaction spots for 
interaction of CDC25B with 14-3-3γ, 14-3-3ε, 14-3-3ζ, 14-3-3η, 14-3-3τ and 14-3-3σ. 
For interaction of CDC25B with each of the six 14-3-3 isoforms, shown are images of an 
oocyte (top panel) and an egg (bottom panel) at an equatorial plane of a single confocal 
68 
 
 
 
scan (left), a compressed z stack of all confocal scans throughout the cell (middle), and 
bright field images (right). Interactions of each of the six 14-3-3 isoforms with CDC25B 
were noted by bright, fluorescent PLA reaction spots throughout cytoplasm and germinal 
vesicle of oocytes, with reduced interactions in eggs. Scale bars represent 10 μm.  
 
It is not possible to compare the results (the number of interaction sites, for 
example) among the different 14-3-3 isoforms because of differences in primary antibody 
binding affinities and the likely variations in the amounts of PLA reagents used between 
experiments despite using the same protocol; however again, interactions of all isoforms 
of 14-3-3 with CDC25B appear to be reduced in eggs compared to oocytes, as eggs and 
oocytes were processed at the same time.  The reduction in the average number of in situ 
PLA sites of interaction of 14-3-3 isoforms with CDC25B in eggs compared to oocytes, 
ranged from 12% for 14-3-3τ to 78% for 14-3-3γ as shown in Figure 6.  
 
69 
 
 
 
 
Figure 6. Per cent PLA sites of interaction of seven mammalian 14-3-3 isoforms with 
CDC25B in mouse eggs compared to oocytes. For interaction of CDC25B with each 
14-3-3 isoform, the average number of PLA spots counted in all oocytes examined, was 
considered 100% (dashed line), relative to which the average number of PLA spots in 
eggs was represented as a per cent, mentioned on top of the corresponding bar. As shown, 
the interactions of all 14-3-3 isoforms with CDC25B were found to decrease during 
maturation of oocytes into eggs. 
 
Co-immunoprecipitation studies indicate interaction of all 14-3-3 isoforms with 
CDC25B in mouse ovaries and oocytes, with reduced interactions in eggs 
CDC25B was successfully pulled down by goat anti-CDC25B antibody from 
protein extracts of ovaries, oocytes as well as eggs of adult mice (Figure 7A).  Protein 
extract from ovary was used as a positive control (Figure 7A, lane 1).  In this whole 
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ovarian extract, two forms of CDC25B are apparent: one band at about 72 kDa and one 
band at about 45 kDa.  A negative control using normal rabbit serum showed only heavy 
and light chain of the antibodies, indicating no non-specific protein bound to the beads 
(Figure 7A lane 2).  CDC25B was identified as a 72 kDa band immunoprecipitated from 
ovarian extracts (Figure 7A lane 3) as well as oocytes (Figure 7A lane 4).  In eggs, a 72 
kDa band corresponding to CDC25B was not detected. We suspect (as shown in the next 
section) that CDC25B is present at smaller molecular weight (45 kDa) as a 
dephosphorylated protein and is masked by the thick band for the antibody heavy chain 
(50 kDa) (Figure 7A lane 5).  
To determine which of the 14-3-3 isoforms might be co-immunoprecipated with 
CDC25B, the Western blot membrane was stripped and first re-probed with anti-14-3-3β 
(Figure 7B) and then the membrane was stripped and re-probed with the other rabbit anti-
14-3-3 isoform-specific antibodies one at a time after stripping off the previously bound 
antibodies. After each isoform probe, the blot was completely stripped and tested for the 
presence of residual primary antibody previously bound.  At each step, stripping the 
membrane and incubation in secondary antibody alone displayed no band, confirming 
complete removal of previously bound antibodies (Figure 7B) at the expected 14-3-3 
molecular weight of around 30 kDa, except for 14-3-3σ. It was previously found that the 
anti-14-3-3σ primary antibody does not appear to detect 14-3-3σ by Western blotting due 
to possible unsuitability of the antibody used in recognizing a denatured antigen (though 
the antibody is effective in fixed cells using immunofluorescence [49].   Again, it is not 
possible to compare the protein amounts for the different isoforms as the isoform-specific 
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antibodies have different affinities and therefore may exhibit different intensities on a 
Western blot; however, the co-immunoprecipitation experiment revealed 14-3-3 bands 
with lesser intensity in eggs as compared to oocytes, for all of the six 14-3-3 isoforms.  
At the end of the series of re-probing the same membrane for six other isoforms, a 
prominent band was detected with the same 14-3-3β antibody (Figure 7C), confirming no 
significant loss of proteins by repeated membrane stripping.  
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Figure 7. Co-immunoprecipitation of 14-3-3 isoforms with CDC25B phosphatase. 
CDC25B was immunoprecipitated from extracts of ovaries, oocytes and eggs (A). 
Phosphorylated CDC25B was observed to be pulled down from lysates of ovaries and 
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oocytes (A), dephosphorylated CDC25B in eggs possibly being masked by the thick band 
for the antibody’s heavy chain. This was followed by repeatedly stripping the blot off the 
previously bound antibodies and reprobing with each 14-3-3 isoform-specific antibody 
except 14-3-3 sigma (B). All isoforms of 14-3-3 appear to co-immunoprecipitate with 
CDC25B in ovaries and oocytes detected by prominent bands, with reduced band 
intensities in eggs (B). In the end, the blot was reprobed again for 14-3-3β to confirm 
minimal loss of proteins by repeated membrane stripping (C). Ovary lysate was used as 
positive control (PC) and normal rabbit serum was used as negative control (NC).    
 
The co-immunoprecipitation results indicate that six of the seven mammalian   
14-3-3 isoforms are co-immunoprecipitated with CDC25B.  Thus, the co-
immunoprecipitation experiment confirms the PLA results indicating that all isoforms of 
14-3-3 interact with CDC25B in oocytes and to some extent in eggs. 
Using In Situ Proximity Ligation Assays, it is demonstrated for the first time that 
all seven mammalian isoforms of 14-3-3 interact with CDC25B in adult mouse oocytes 
and eggs.  Lesser percentages of In Situ PLA sites for interactions of CDC25B with all 
isoforms of 14-3-3 were found in eggs as compared to oocytes.  Co-immunoprecipitation 
studies also showed interaction of six 14-3-3 isoforms with CDC25B in mouse oocytes 
and eggs, with reduced interactions for all 14-3-3 isoforms in eggs as compared to 
oocytes. 
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CDC25B and its phosphorylation in mouse oocytes and eggs   
The 14-3-3 proteins are known to generally bind to phosphorylated proteins.   
Therefore I explored, in part, the phosphorylation status of CDC25B to begin work on the 
nature of 14-3-3 binding.  While comparing extracts of oocytes and eggs, a 72 kDa band 
was detected in oocytes but not in eggs, by Western blotting (Figure 8). However, a 45 
kDa band was observed in eggs.  To further explore the difference in molecular weights 
of CDC25B in oocytes and eggs, extracts of oocytes and eggs were treated with the 
bacteriophage λ protein phosphatase to dephosphorylate serine, threonine and tyrosine 
residues in all proteins. A 45 kDa band was found in the λ protein phosphatase-treated 
oocyte extract.  This band at 45kDa matches the band found in untreated or λ 
phosphatase-treated egg extracts. This suggests a clear and dramatic dephosphorylation 
of the CDC25B in eggs at multiple sites.   
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Figure 8. Western blot detecting CDC25B phosphorylation in oocytes versus eggs by 
λ-phosphatase treatment. CDC25B is phosphorylated in oocytes (72 kDa band; lane 1) 
and dephosphorylated in eggs (45 kDa band; lane 3). Treatment with λ-phosphatase 
results in dephosphorylation of the protein in oocytes (45 kDa band; lane 2), and remains 
dephosphorylated in eggs (45 kDa band; lane 4).  
 
CDC25B phosphorylation status in mouse oocytes and eggs at Ser-149 
Previous research has shown that mouse CDC25B can be phosphorylated at Ser-
321 by PKA in oocytes [9] and in fertilized eggs [71].  Ser-149 was recently reported to 
be a second site of phosphorylation on CDC25B in fertilized mouse eggs (zygotes) [72].  
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While the PKA-dependent phosphorylation of CDC25B in mouse oocytes and fertilized 
eggs at Ser-321 is fairly well characterized [9, 71], PKA-dependent phosphorylation of 
CDC25B phosphorylation at Ser-149 is also of interest but has not been examined in 
oocytes.  The Ser-321 residue of CDC25B has been identified as a direct target of PKA in 
prophase I-arrested oocytes, and phosphorylation at this site results in inhibition of 
CDC25B and its sequestration by the 14-3-3 protein [10].  Protein 14-3-3ε has been 
reported to interact with phospho-Ser321-CDC25B, to maintain the prophase I arrest of 
the mouse oocyte [73].  However, the role of CDC25B phosphorylation at Ser-149 has 
not yet been investigated in relation to maintenance of prophase I arrest in mouse 
oocytes.  In this project, this phosphorylation in oocytes and unfertilized eggs was 
examined through Western blotting, immunofluorescence and the PLA method. 
A single band at 72 kDa was detected in mouse oocytes with a rabbit anti-
phospho-Ser149 antibody; while no bands could be detected in eggs (Figure 9).  In 
immunofluorescence experiments, phosphorylation of CDC25B at Ser-149 was detected 
abundantly in cytoplasm of oocytes compared to the corresponding germinal vesicles 
(Figure 9A) but appeared to be reduced in eggs (Figure 9C).  To provide some additional 
evidence for the presence and potential role of Ser149-phosphorylated CDC25B in mouse 
oocytes an in situ proximity ligation assay was conducted using two antibodies, both 
directed at CDC25B.  In this case the interactions of different proteins were not 
examined; instead, different antibody epitopes on the same protein were utilized.  This 
PLA assay utilized the goat anti-CDC25B and the rabbit anti-phospho-Ser149-CDC25B 
which binds to the same protein if it is phosphorylated at Ser-149.  Prominent PLA 
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reaction spots were observed throughout all mouse oocytes examined, indicating clearly 
that CDC25B in oocytes is phosphorylated at Ser-149 (Figure 9G-H).  Eight oocytes and 
eight eggs were studied for the experiment, and fewer reaction sites were identified in 
eggs compared to oocytes (Figure 9J-K).  A 35.5% reduction in the number of PLA 
interaction sites was observed in eggs compared to oocytes, suggesting some 
dephosphorylation of CDC25B at Ser-149 during oocyte maturation.  Although we have 
not further quantified this change, the results agree with the reduction of phosphorylated 
CDC25B as evidenced by Western blotting and immunocytochemistry, which suggest 
that CDC25B is dephosphorylated in eggs.  Such a Western blot may not be sensitive 
enough to detect any residual phosphorylation that can be observed at the molecular level 
with the much more sensitive PLA method.  All of three control oocytes as well as three 
control eggs treated simultaneously in absence of primary antibodies, showed no PLA 
reaction spot (Figure 9M-N and P-Q).        
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Figure 9. CDC25B is phosphorylated at Ser149 in oocytes, and the phosphorylation 
is reduced in eggs. Shown on top left is a Western blot detecting phosphoSer149-
CDC25B in oocytes but not in eggs. A representative oocyte (A: fluorescence; B: bright 
field) and a representative egg (C: fluorescence; D: bright field) show 
immunocytochemistry detecting greater phosphorylation of CDC25B at Ser149 in 
cytoplasm compared to germinal vesicle of oocytes (A), with reduced phosphorylation in 
eggs (C). Minimal background staining was noted in control oocytes and eggs processed 
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simultaneously in absence of the primary antibody (E). Bright, fluorescent PLA reaction 
spots indicating sites of phosphorylation of CDC25B at Ser-149 were noted in oocytes 
(G-I), with reduced number of the PLA spots in eggs (J-L). Shown are representative 
images at an equatorial plane of a single confocal scan (G, J), a compressed z stack of all 
confocal scans throughout the cell (H, K), and bright field images (I, L). No PLA reaction 
spot was noted in control oocytes (M-O) and control eggs (P-R) processed 
simultaneously in absence of primary antibodies. Scale bars represent 10 μm.  
 
The PLA method is highly sensitive and can identify molecular interactions that 
are below the limit of detection by Western blotting, evident from the Western blot in 
figure 9 and the PLA data in figure 9H, K. Phosphorylated CDC25B was detected in 
adult mouse oocytes along with the likely dephosphorylated form of the protein in eggs, 
by λ-phosphatase treatment and Western blotting, evident from Figure 8.  The data 
correlates with the previously reported result [10] that during maturation of the mouse 
oocyte by germinal vesicle breakdown, CDC25B translocates and accumulates in the 
germinal vesicle, inferred from Figure 3.  
 
Microinjection of the 14-3-3-inhibitory peptide R18 and antisense morpholino 
against 14-3-3η mRNA induces significant maturation of mouse oocytes 
As mentioned before, mouse oocytes are held in prophase I meiotic arrest in the 
ovary by elevated cAMP (maintained by adenylyl cyclase activity and reduced cAMP 
phosphodiesterase activity) that sustains PKA activity to activate Wee2 kinase and 
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inactivate CDC25B, thus keeping CDK1 inactive and maintaining meiotic arrest.  Central 
to this mechanism for meiotic arrest may be the requirement that CDC25B is 
phosphorylated and that, phosphorylated CDC25B is held in an inactive state be being 
bound to 14-3-3 proteins.  Indeed, evidence form a variety of experiments indicates that a 
primary role for 14-3-3 proteins may be to sequester and preserve the phosphorylated 
status of proteins in many cellular processes.  Therefore, to demonstrate directly in mouse 
oocytes that 14-3-3/CDC25B interaction is required for meiotic arrest, a series of 
experiments was conducted to disrupt the interaction, with the hypothesis that preventing 
the interaction of CDC25B with 14-3-3 proteins would lead to oocyte maturation, once 
the CDC25B becomes free to dephosphorylate CDK1, thereby activating MPF.   
It is well known that elevated cAMP levels within the oocyte maintains prophase 
arrest and that, oocytes spontaneously resume meiosis and mature as the cAMP 
concentration falls when oocytes are removed from the ovarian follicle [17, 74-76].   
Maintenance of meiotic arrest in isolated oocytes can be achieved by agents that activate 
adenylyl cyclase or by application of membrane-permeable cAMP analogs including 
dibutyryl-cAMP (dbcAMP) [77]. 
Typically, a concentration of 0.1 mg/mL dbcAMP in the oocyte collection 
medium is sufficient to maintain meiotic arrest in isolated mouse oocytes.  For 
experiments involving microinjection of R18 or antisense morpholinos against the 14-3-3 
isoforms, the threshold or critical concentration of dbcAMP, which is just sufficient to 
maintain prophase I arrest in at least 75% of oocytes cultured overnight, was determined 
to be 0.05 mg/mL.  Oocyte maturation experiments in this concentration of dbcAMP 
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permitted us to examine treatments that could promote maturation compared to control 
cells in which meiotic arrest is maintained, but not dominated by the activation of PKA 
by dbcAMP.  
In a preliminary experiment to examine 14-3-3 protein function, mouse oocytes 
were microinjected with the synthetic 14-3-3-inhibitory peptide R18.  Microinjection of 
0.5 μg/μL (final intracellular concentration) of R18 into oocytes, followed by overnight 
incubation in media containing 0.05 mg/mL dibutyryl cAMP, promoted release from 
meiotic arrest and GVBD in a larger number of cells compared to uninjected control 
oocytes or control oocytes injected with deionized water.  Ten of 15 (67%) of oocytes 
underwent GVBD following R-18 injection while only 4/16 (25%) did so when injected 
with deionized water and only 5 of 18 (28%) control uninjected oocytes (Figures 10A and 
11).  Statistical analysis of 2X2 contingency tables using Fisher’s exact test indicated a 
significant difference in per cent GVBD among the experimental and control groups of 
cells.  Pairwise comparison of the percentage of GVBD in the uninjected cells and those 
injected with water revealed no significance difference.  Pairwise comparison of the R18 
injected and the control water-injected cells revealed a significant difference (P<0.05).  
The effectiveness of R-18 inhibition is certainly concentration-dependent; however the 
injection of a more concentrated peptide solution was not possible.  In addition, of 
course, some CDC25B may still be held phosphorylated by residual PKA kept active by 
the 0.05mg/mL dibutyryl cAMP.  Nevertheless, the experiment suggests that inhibiting 
some interactions of 14-3-3 with its binding partners, here including CDC25B, shifts the 
balance between phosphorylated and unphosphorylated forms of CDC25B.  This may be 
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true in part, perhaps because some CDC25B is no longer sequestered by 14-3-3 and is 
likely dephosphorylated, even in the presence of some PKA activity.  To further 
investigate this possibility, the more specific approach of reducing 14-3-3 protein rather 
than inhibiting its action, was chosen.  This would also help to identify which of the     
14-3-3 isoforms might be primarily responsible for binding to CDC25B and preventing 
oocyte maturation. 
In a series of experiments for each 14-3-3 isoform, while in prophase I arrest, GV-
intact oocytes were microinjected with a translation-blocking morpholino oligonucleotide 
against each of the 14-3-3 isoforms at a final intracellular concentration of 0.1 mM.  The 
oocytes were held for 24 hours in prophase arrest with media containing 0.1 mg/mL 
dbAMP to permit a reduction of the existing 14-3-3 protein isoform.  The oocytes were 
then transferred to 0.05 mg/mL dbcAMP and incubated for 13-14 hours, stained with 
Hoechst and then examined for GVBD.  
A high percentage (70%) of oocytes injected with MO against 14-3-3η were 
found to have undergone GVBD, in contrast with oocytes injected with MOs targeting 
other 14-3-3 isoforms (Figures 10B and 12).  Under these conditions in this series of 
experiments, GVBD in control uninjected oocytes was about 7.5% and only about 5% for 
oocytes injected with a standard, nonsense morpholino oligonucleotide incapable of 
binding to any of the 14-3-3 mRNAs.  Statistical analysis of 2x2 contingency tables using 
Fisher’s exact test indicated no significance difference between GVBD in the uninjected 
cells and in cells injected with the standard, nonsense morpholino.  Pairwise comparison 
of each of the 14-3-3 isoform morpholino injection conditions with the nonsense 
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morpholino control revealed no significant difference between the control and the 
experimental group, with the exception of 14-3-3η (two-tailed P value of less than 
0.0001).   
  
 
Figure 10. The 14-3-3 proteins, specifically 14-3-3η, is required for maintaining 
prophase I arrest of oocytes. Shown are per cent germinal vesicle breakdown (GVBD) 
following in vitro maturation of mouse oocytes microinjected with the 14-3-3-inhibitory 
peptide R18 (A) and antisense morpholinos against each of the seven mammalian 14-3-3 
isoforms (B). At each injection condition, the number of cells with GVBD was 
represented as a per cent of the total number of cells studied, mentioned on top the 
corresponding bar. A significantly greater percentage of GVBD was noted for oocytes 
injected with R18 compared to control (* in A), as well as for oocytes injected with the 
morpholino targeting 14-3-3η mRNA compared to control (* in B).   
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Figure 11. Representative mouse oocytes showing maturation-promoting effect of 
14-3-3-inhibitory peptide R18, compared to controls. Intact germinal vesicle (GV) was 
noted in control uninjected oocytes (A, B) as well as water-injected oocytes (C, D).  In 
contrast, germinal vesicle breakdown (GVBD) was observed along with condensed 
metaphase chromosomes and first polar body formation from oocytes microinjected with 
R18 (E, F). DNA was stained blue with Hoechst. PB: First polar body. Scale bars 
represent 10 μm. 
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Figure 12. Representative mouse oocytes showing maturation-promoting effect of 
antisense morpholino against 14-3-3η, compared to control. Intact germinal vesicle 
(GV) was noted in control oocytes (A, B).  In contrast, germinal vesicle breakdown 
(GVBD) was observed along with condensed metaphase chromosomes in oocytes 
microinjected with a translation-blocking morpholino oligonucleotide targeting 14-3-3η 
(C, D). DNA was stained blue with Hoechst. Scale bars represent 10 μm. 
 
These results suggest that among the seven mammalian isoforms of 14-3-3 
proteins, all of which were found to bind to CDC25B in mouse oocytes and eggs to 
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varying extents, 14-3-3η is functionally important for maintaining the prophase I arrest of 
mouse oocytes.  Reduction of 14-3-3η protein by morpholino-mediated knockdown of 
14-3-3η protein synthesis is likely to provide fewer binding sites for CDC25B that would 
maintain it in the inactive state tipping that balance, at least in some cells, to favor the 
activation of MPF even in presence of residual PKA activity associated with the 0.05 
mg/mL dibutyryl cAMP in which the MO-injected oocytes were incubated overnight. 
The R18 peptide shares a common binding site on 14-3-3 with other 14-3-3 
binding partners and peptide R18 competes with 14-3-3 binding partners [78]; thus R18 
can displace proteins bound to 14-3-3.  The interaction of R18 does not depend on the  
14-3-3 isoform and the peptide does not require prior phosphorylation for binding.  The 
utility of the R18 peptide has been demonstrated, for example, to show that 14-3-3 is a 
critical regulator of anti-apoptotic signaling in various cells [79, 80], including cultured 
ovarian granulosa cells [81].  Introduction of R18 message in frog eggs produced defects 
in axial patterning and mesoderm specification [82].  Microinjection of oocytes with the 
14-3-3-inhibitory peptide R18 showed about 40% greater maturation compared to 
uninjected control oocytes or control oocytes injected with sterile, deionized water.  
Microinjection of GV-intact mouse oocytes with a translation-blocking MO against 14-3-
3η, followed by in vitro maturation, showed a majority of oocytes to undergo maturation, 
unlike oocytes injected with MOs against other 14-3-3 isoforms. This suggests that 14-3-
3η is essential for maintaining meiotic arrest of mouse oocytes.  
Dephosphorylation of one or more phosphorylation sites on CDC25B might 
activate the protein to cause GVBD during mouse oocyte maturation. In mouse oocytes, 
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the specific 14-3-3 isoform, namely 14-3-3η, whose knockdown appears to activate 
GVBD, may be bound to CDC25B phosphorylated at a site different from the site(s) at 
which CDC25B is phosphorylated and bound to other 14-3-3 isoforms.  As reported in 
chapter 4, by morpholino-mediated knockdown method it was found that the same 
isoform of 14-3-3 protein, namely 14-3-3η, is essential for normal meiotic spindle 
formation during mouse oocyte maturation by interacting with α-tubulin, in part, to 
regulate the assembly of microtubules [54].  Thus, 14-3-3η appears to play a key role in 
not only maintaining the prophase I arrest of mouse oocytes, but also in the regulation of 
meiotic spindle assembly during maturation of the oocyte.  
 
 
Materials and Methods 
 
Collection of Oocytes and Eggs and Preparation of Ovarian Tissue Extract   
All mice used in the present experiments were housed and used at Kent State 
University under an approved Institutional Animal Care and Use Committee protocol 
following the National Research Council's publication Guide for the Care and Use of 
Laboratory Animals.  To obtain oocytes, CF1 mice (2.5 months old) were injected with 
7.5 IU eCG and, 44-48 hours later, the ovaries were removed and repeatedly punctured 
with a 26-gauge needle to rupture follicles. Cumulus cell-enclosed oocytes were isolated 
and the cumulus cells were removed by repeated pipetting though a small-bore pipette. 
Fully-grown oocytes with intact nuclei (germinal vesicles) were cultured in MEMα 
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containing 0.1 mg/ml dibutyryl cAMP to prevent spontaneous oocyte maturation. Mature, 
metaphase II-arrested eggs were obtained from mice 13-14 hours following 
superovulation by injection of 7.5 IU hCG which was preceded by a priming injection of 
7.5 IU eCG injection 48 hrs earlier.  The cumulus cells were removed with 0.3 mg/ml 
hyaluronidase.  Zonae pellucidae from oocytes and eggs thus collected were removed by 
a brief treatment in acid Tyrode's solution (0.14 M NaCl, 3 mM KCl, 1.6 mM 
CaCl2.2H2O, 0.5 mM MgCl2.6H2O, 5.5 mM glucose, and 0.1% PVA, pH 2.5). Cells were 
then used for Western blot, immunofluorescence studies, Duolink In Situ Proximity 
Ligation Assays or co-immunoprecipitation studies as described below. For Western 
blotting and co-immunoprecipitation experiments, cells collected as above were rinsed in 
MEMα, counted, and transferred to Tris-buffered saline (TBS; 150 mM NaCl, 25 mM 
Tris-HCl, pH 7.5) containing 0.1% PVA and the transferred in a small volume to a 
microentrifuge tube, lysis buffer was added, and the cell lysates were quick-frozen in 
ethanol/dry ice and stored at -70°C until use. The lysis buffer contained 10 mM Tris-HCl 
at pH 7.2, 1 mM EDTA, 1 mM EGTA, 0.1% (v/v) b-mercaptoethanol, 1% (v/v) Triton X-
100, protease inhibitors (1 mM PMSF, 0.1 mM TPCK), and phosphatase inhibitors (1 
mM Na3VO4, 50 mM NaF, 10 mM beta-glycerophosphate and 5 mM sodium 
pyrophosphate).  
Ovaries from unprimed adult mice (2.5 months old) were homogenized in a buffer 
containing (10 mM Tris pH 7.0, 1 mM EDTA, 1 mM EGTA, 0.16% benzamidine 
hydrochloride, 14 mM beta-mercaptoethanol, 1 mM PMSF and 0.1 mM TPCK) pH 7.2, 
using a mechanical homogenizer. The homogenized cell lysates were then centrifuged at 
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16,000 g for 30 minutes and the supernatants containing the total soluble protein extracts 
were used for Western blotting or co-immunoprecipitation studies. 
 
Immunofluorescence 
To examine the initial stages of oocyte maturation, oocytes were isolated in MEM 
containing 0.1 mg/mL dbcAMP and examined by confocal immunoforescence 
microscopy using a rabbit anti-CDC25B.  Cells were fixed immediately in  3.7% 
formaldehyde (Time 0; 7 cells), or fixed at 30 minutes (12 cells), 1 hour (8 cells) and 2 
hours (6 cells) after transfer to MEMα containing no dbcAMP.  After fixation, the 
oocytes and eggs were washed in PBS-PVA (PBS containing 1% PVA), permeabilized 
with 1% TritonX-100 to promote antibody penetration, washed in PBS-PVA,  treated 
with blocking buffer (5% normal donkey serum) and incubated overnight with primary 
antibody.  Following washing in blocking buffer (1% donkey serum), the cells were 
incubated with appropriate secondary antibody for several hours, washed again, and 
individually imaged with the Olympus Fluoview FV500 confocal microscopy system 
using a 60X oil immersion lens and various confocal zooms; the scale bars on the images 
indicate the final magnification. Images were captured and examined at multiple confocal 
planes. The representative images shown here are primarily images at the plane of the 
optical equator or the cell or of the nucleus.  The primary antibody used in the time 
course assay was rabbit anti-CDC25B (Proteintech; #10644-1-AP) diluted 1:200, and the 
secondary antibody used was donkey anti-rabbit (549 nm-conjugated; Jackson 
ImmunoResearch Laboratories) diluted 1:200.  Dilutions were made in 1% donkey serum 
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blocking buffer.  Three control oocytes were processed through identical procedure stated 
above, but without incubation in the primary antibody.  To confirm the detection of 
CDC25B, a different primary antibody (goat anti-CDC25B, Santa Cruz; sc-6948) and 
488 nm-conjugated donkey anti-goat secondary antibody (Jackson Laboratories) were 
also used in 12 other oocytes (not shown).   
 
In Situ Proximity Ligation Assays (PLA) to detect interaction of 14-3-3 isoforms 
with CDC25B in mouse oocytes versus eggs 
Duolink in situ PLA probes, blocking solution, antibody diluents, wash buffers A 
and B, and detection reagents were obtained from OLink Bioscience. Following fixation 
and permeabilization, the cells were processed following the manufacturer’s instructions 
for the Duolink in situ PLA kit. The cells were transferred to DuoLink in situ blocking 
buffer and then incubated overnight in presence of both the primary antibody for the 14-
3-3 isoform (rabbit anti-14-3-3 isoform panel PAN017, AbD Serotec; diluted 1:200 in 
Duolink in situ antibody diluent) and that for CDC25B (goat anti-CDC25B, Santa Cruz, 
sc-6948; diluted 1:200 in Duolink in situ antibody diluent). Following washing in 1X 
DuoLink Wash Buffer A (diluted from 10X stock with deionised water), the cells were 
incubated in anti-rabbit DuoLink PLUS PLA probe secondary antibody (diluted 1:5 in 
DuoLink in situ Antibody Diluent) and anti-goat DuoLink MINUS PLA probe secondary 
antibody  (diluted 1:5 in DuoLink in situ Antibody Diluent) for two hours in a humidified 
chamber.  Cells were then washed in 1X DuoLink Wash Buffer A, incubated in Ligase-
Ligation mixture for 30 minutes at 37ºC in a humidified chamber, washed again, 
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incubated in Polymerase-Amplification mixture for 100 minutes at 37ºC in a humidified 
chamber, then washed in 1X DuoLink Wash Buffer B and 0.01X Duolink wash buffer B 
(diluted from 10X stock with deionised water).  The oocytes and eggs were transferred 
into a droplet of PBS containing 1% PVA with SlowFade (Invitrogen) under oil for 
confocal imaging as described for immunofluorescence.  Confocal z-stack images of cells 
were captured at 3um thickness intervals, at a zoom setting of 2.5, through multiple 
oocytes and eggs for each isoform tested.  The number of interactions of CDC25B with 
each of the 14-3-3 isoforms was determined by counting the PLA reaction sites in 
consecutive images taken at 3 µm intervals throughout the oocytes and eggs (using Image 
J software with visual confirmation).  In two such experiments, PLA reaction spots for 
interaction of CDC25B with each 14-3-3 isoform were imaged in a total of seven to 10 
different oocytes and in a total of six to 11 different eggs.  A comparison between 
oocytes and eggs was made for CDC25B interactions with each of the 14-3-3 isoforms.  
For comparison of the interaction of CDC25B with each 14-3-3 isoform, the average 
number of PLA spots in oocytes was considered 100%, relative to which the average 
number of PLA spots in eggs was represented.  Six control oocytes and six control eggs 
were processed simultaneously for in situ PLA following identical procedure in absence 
of the primary antibodies.   
To confirm that the PLA method was effective in identifying the close proximity 
of two different antibodies under the conditions used in these experiments, three oocytes 
were processed for in situ PLA using two different antibodies to CDC25B.  In this case 
the each of the antibodies was targeted to the same protein.  The first was an antibody 
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raised in goat against a peptide mapping at the N-terminus of CDC25B of human origin, 
which reacts also with mouse CDC25B.  This antibody was used in studying 14-3-3 and 
CDC25B intractions, and the second antibody was made in rabbit against a different 
epitope of CDC25B of human origin, which is known to react with mouse CDC25B.  
Three control oocytes were processed simultaneously for in situ PLA following identical 
procedure in absence of the primary antibodies. 
The 14-3-3 antibodies used in this report have been used to detect the different 
14-3-3 isoforms in mouse ovaries, oocytes and eggs by Western blotting, 
immunocytochemistry and immunohistochemistry cells within ovarian sections [49]. 
Martin and his colleagues described the generation of the panel of antibodies and used 
them to detect the major brain isoforms of 14-3-3.  They confirmed, by several methods, 
the high specificity of each of these antibodies, which is due to the fact that the epitope 
for each antibody is mainly in the N-acetylated amino terminus of the different peptide 
immunogens for 14-3-3 isoforms [68-70].  The panel of 14-3-3 isoform-specific 
antibodies was also used to identify the isoforms of 14-3-3 proteins expressed in human 
dermal and epidermal layers [83] and in adrenal chromaffin cells [70].  
 
Co-immunoprecipitation studies, membrane stripping and reprobing 
Four µg of goat anti-CDC25B antibody (Santa Cruz) added to Protein G 
Sepharose (GE Healthcare) was used to bind CDC25B in 1 mg of total protein extracts 
from ovaries, oocytes and eggs.  After incubation with rotation for 1 hour at 4ºC, the 
beads were centrifuged at 4000 rpm for 1 minute, washed twice with 1X TBS containing 
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0.1% Tween-20, and then once with homogenization buffer containing protease inhibitors 
and phosphatase inhibitors (homogenization buffer containing 10 mM Tris-HCl [pH 7.2], 
1 mM EDTA, 1 mM EGTA, 0.1% (v/v) beta-mercaptoethanol, 1% (v/v) Triton X-100, 
protease inhibitors [1 mM PMSF, 0.1 mM TPCK] and phosphatase inhibitors [1 mM 
Na3VO4, 50 mM NaF, 10 mM beta-glycerophosphate, and 5 mM sodium pyrophosphate]) 
resuspended in homogenization buffer and boiled in sample buffer. The supernatant was 
used for SDS-PAGE and Western blotting using goat anti-CDC25B primary antibody 
(Santa Cruz) diluted 1:100 in blocking buffer (5% non-fat milk in TBS, 0.1% Tween-20) 
and HRP-conjugated donkey anti-goat secondary antibody (Santa Cruz) diluted 1:2000 in 
blocking buffer.  The positive control used normal ovary extract.  The negative control 
used normal rabbit serum IgG (1 µg/µL) in place of the CDC25B antibody.  
Following Western blot transfer, the membrane containing the proteins co-
immunoprecipitated along with CDC25B, was washed in TBS with 0.1% Tween-20, 
incubated in stripping buffer (Thermo Scientific, #46430), washed again in TBS with 
0.1% Tween-20, treated with secondary antibody alone and developed to confirm 
complete removal of previously bound antibodies. This was followed by incubating the 
membrane in blocking buffer and re-probing with each of the rabbit anti-14-3-3 isoform-
specific primary antibodies (AbD Serotec; PAN017), one at a time, diluted 1:1000 in 
blocking buffer and HRP-conjugated goat anti-rabbit secondary (Santa Cruz) diluted 
1:2000 in blocking buffer. In the end, the membrane was stripped and reprobed with 
rabbit anti-14-3-3β (AbD Serotec) primary antibody (since this was the first of all the 
antibodies used to detect the 14-3-3 isoforms co-immunoprecipitated along with 
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CDC25B) and HRP-conjugated goat anti-rabbit secondary antibody to confirm that there 
was minimal loss of proteins by repeated membrane stripping. 
 
SDS-PAGE and Western Blotting 
Total protein extracts from 200 oocytes and 200 eggs were prepared in presence 
of protease inhibitors and phosphatase inhibitors for use in SDS-PAGE and Western 
blotting, along with extracts from 200 oocytes and 200 eggs treated with lambda protein 
phosphatase.  The lysis buffer comprised 10 mM Tris-HCl [pH 7.2], 1 mM EDTA, 1 mM 
EGTA, 0.1% (v/v) beta-mercaptoethanol, 1% (v/v) Triton X-100, protease inhibitors [1 
mM PMSF, 0.1 mM TPCK] and phosphatase inhibitors [1 mM Na3VO4, 50 mM NaF, 10 
mM beta-glycerophosphate, and 5 mM sodium pyrophosphate]).   
For lambda phosphatase treatment, protein extracts from 200 oocytes or 200 eggs 
were incubated with 2 Units/μL of Lambda Protein Phosphatase (New England Biolabs, 
#P0753S) in 1X NE Buffer (50 mM HEPES, 100 mM NaCl, 2 mM DTT, 0.01% Brij 35, 
pH 7.5 at 25°C) supplemented with 1 mM MnCl2 at 30ºC for 2 hours. The protein 
extracts (21 micrograms) were then used for SDS-PAGE and Western blotting by 
following standard procedures, using rabbit anti-CDC25B primary antibody (Proteintech) 
diluted 1:200 in blocking buffer, and HRP- conjugated goat anti-rabbit secondary 
antibody (Genscript) diluted 1:2000 in blocking buffer.  
Proteins from the lysates of 200 oocytes and 200 eggs were separated by SDS-
PAGE using a 4% stacking, 12% resolving polyacrylamide gel and electrophoretically 
transferred to Immobilon-P PVDF membrane (Millipore Corp.). The membranes were 
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incubated in blocking buffer (5% non-fat milk in TBS, 0.1% Tween-20) and then with 
primary antibodies overnight at 4°C, washed and incubated with secondary antibody and 
imaged by chemiluminescence with an enhanced chemiluminescence kit according to the 
manufacturer’s instructions (GE Healthcare Life Sciences) using Fujifilm LAS-3000 
developer.  
The commercial rabbit anti-CDC25B (#10644-1-AP) primary antibody 
(Proteintech) was utilized for Western blotting to detect CDC25B in mouse oocytes and 
eggs, raised against the N-terminus of CDC25B of human origin. The antibody was used 
at a dilution of 1:200 in blocking buffer (5% milk in 1X TBS, 0.1% Tween-20). The 
secondary antibody used was HRP-conjugated goat anti-rabbit (Genscript; 1 mg/ml 
stock) used at a dilution of 1:2000 in the blocking buffer. 
 
Detection of phospho-Ser-149-CDC25B by Western blot and immunofluorescence 
Protein extracts of 200 oocytes and 200 eggs were used for SDS-PAGE and 
Western blotting using rabbit anti-pSer149-CDC25B (Signalway; #11553) primary 
antibody and HRP-conjugated goat anti-rabbit secondary antibody, following standard 
procedure as stated above.  Five oocytes and six eggs were also processed for 
immunofluorescence staining of pSer149-CDC25B using this antibody following the 
methods described above.  Four control oocytes and four control eggs were processed 
simultaneously for immunocytochemistry following identical procedure in absence of the 
primary antibody, to ensure minimal background staining.  
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In Situ PLA to detect phosphorylation of CDC25B at Ser-149 in oocytes versus eggs 
Duolink In Situ PLA was performed on eight oocytes and eight eggs, following 
the manufacturer’s protocol and as described above, using rabbit anti-pSer149-CDC25B 
(Signalway; #11553) and goat anti-CDC25B (Santa Cruz; sc-6948) primary antibodies.  
Three control oocytes and three control eggs were treated simultaneously following 
identical protocol in absence of primary antibodies, to confirm that there was minimal 
non-specific reaction.  The In Situ PLA spots in each experimental cell studied were 
counted (using Image J software with visual confirmation) in consecutive 3 µm sections 
throughout the oocytes and eggs.  A comparison between oocytes and eggs was made for 
the interaction reactions noted for CDC25B and pSer149-CDC25B as a way of 
examining the phosphorylation status of CDC25B.  For comparison, the average number 
of PLA spots in oocytes was normalized to 100%, relative to which the average number 
of spots in eggs was expressed as a percentage.  
 
Figure 13. Schematic experimental approach to detect phosphorylation of CDC25B 
at Ser-149 by in situ Proximity Ligation Assay. The assay was performed by standard 
procedure on fixed mouse oocytes and eggs, using goat anti-CDC25B (Santa Cruz 
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Biotechnology) and rabbit anti-phospho-Ser149-CDC25B (Signalway) primary 
antibodies. Detection of bright fluorescent in situ PLA reaction spots would indicate 
CDC25B phosphorylated at Ser-149.      
 
Microinjection of R18 
Ten pL of a 10 mg/mL stock solution of R18 peptide (Enzo Life Sciences) 
dissolved in sterile deionized water was microinjected by semi-quantitative method into 
mouse oocytes isolated from adult CF1 mice, to inhibit interactions of all isoforms of 14-
3-3 with their binding partners including CDC25B.  Following injection the cells were 
transferred through several washes and incubated in bicarbonate-buffered MEMα 
containing threshold concentration of dibutyryl cAMP (0.05mg/mL) in presence of 5% 
CO2 at 37°C for 13 hours and then examined. Controls included oocytes processed 
simultaneously through identical procedure, following injection of 10 pL sterile 
deionized water or no injection.  The number of cells with completed GVBD 
corresponding to injection of R18 was then graphically represented, comparing to water-
injected and uninjected control cells.   
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Figure 14. Schematic experimental approach of inhibition of interactions of 14-3-3 
proteins with CDC25B by intracytoplasmic microinjection of R18 into mouse 
oocytes. R18, a known 14-3-3-inhibitory peptide, would competitively block binding 
interactions of all isoforms of 14-3-3 with CDC25B. Release of CDC25B from 14-3-3 
destabilizes its phosphorylation, enabling it to cause germinal vesicle breakdown 
(GVBD) and maturation of the oocyte.   
To determine the threshold or critical concentration of dbcAMP required for 
maintaining prophase I arrest of oocytes, GV-intact oocytes were isolated from adult CF1 
mice by standard procedures as described before. Several dilutions of bicarbonate-
buffered MEMα containing stock 0.1 mg/mL dbcAMP were prepared. A number of 
oocytes were incubated in drop cultures of media with various dilutions of the stock 
dbcAMP and some in media with no dbcAMP, under mineral oil, at 37°C in presence of 
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5% carbon dioxide. The cells were examined after 13 hours of incubation and scored 
under the stereoscope for intact GV or GVBD. 
Microinjection of translation-blocking morpholinos against 14-3-3 isoforms 
GV-intact oocytes were isolated from adult CF1 mice (as described before) and 
microinjected with 10 pL of 2 mM stock morpholino oligonucleotide (Gene Tools; final 
concentration 0.1 mM in each cell) against each of the seven 14-3-3 isoforms and 
incubated for 24 hours in bicarbonate-buffered minimal essential medium (Sigma) 
containing full strength stock dbcAMP (0.1 mg/mL) to allow degradation of the existing 
proteins.  A standard picoliter microinjector (Warner Instruments; #PLI-100A) was used 
for the injections.  The cells were then transferred through several washes and incubated 
in bicarbonate-buffered MEMα containing 0.05 mg/mL dbcAMP in presence of 5% CO2 
at 37°C for 13 hours, stained with Hoechst 33342 (B 226, Sigma) and examined for intact 
GV or GVBD along with observation of chromosomes. The number of cells with 
completed GVBD corresponding after injection of morpholino oligonucleotide against 
each of the 14-3-3 isoforms were compared to the number of cells with GVBD in control 
uninjected cells and those injected with a standard, nonsense morpholino.   
For experiments involving microinjections of R-18 and morpholinos against 14-3-
3 isoforms, at each injection condition the cells were classified as having intact GVs or 
having undergone GVBD, therefore a non-paramentric statistical analysis was done using 
Fisher’s exact test (2x2 contingency table).  First, uninjected cells and control injected 
cells (deionized water for R18 experiments and a standard, nonsense morpholino for the 
morpholino experiments) were compared.  Then, each experimental condition was 
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compared to the control injection condition (water or nonsense morpholino). A P value of 
less than 0.05 is considered to indicate a significant difference.  
 
 
Conclusions 
 
All seven mammalian isoforms of 14-3-3 were found interact with CDC25B 
throughout cytoplasm and nuclei of mouse oocytes, with reduced binding for all isoforms 
in eggs compared to oocytes.  CDC25B appears to be phosphorylated at Ser-149 in 
mouse oocytes, and the phosphorylation is reduced in eggs.  Evidence for a decrease in 
interaction of 14-3-3 proteins with CDC25B in eggs is in agreement with the hypothesis 
that 14-3-3 controls mouse oocyte maturation by binding to CDC25B and sequestering it 
in the cytoplasm, preventing premature germinal vesicle breakdown.  Protein 14-3-3η, 
among all isoforms of 14-3-3, appears to be essential for maintaining the prophase I 
arrest in mouse oocytes. 
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CHAPTER 4 
Determination of the requirement of  
14-3-3η (YWHAH) in meiotic spindle 
assembly during mouse oocyte maturation 
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Background 
 
In female mammals, meiosis is initiated prenatally and oocytes remain arrested 
for long periods in an immature state at prophase of the first meiotic division. Within the 
ovary, the oocyte is held in arrest by signals from the surrounding granulosa cells. This 
arrest is released as a result of the preovulatory surge in luteinizing hormone mediated by 
the granulosa cells and activation of maturation promoting factor (MPF) within the 
oocyte. MPF triggers the resumption of meiosis leading to a second arrest at metaphase II 
forming the mature, fertilizable egg [1-4]. In several animals, failure of oocyte maturation 
has been documented and needs to be considered while investigating human female 
infertility [5]. 
Central to this process of oocyte maturation is the correct formation of the 
metaphase spindles that ensure the accurate alignment and separation of chromosomes at 
each meiotic division [6-10]. Centrioles are absent in female mouse oocytes and spindle 
assembly during the two meiotic divisions is therefore independent of centrioles [11]. 
Examination of spindle assembly in live mouse oocytes revealed that the spindle 
assembles from many microtubule organizing centers (MTOCs) that are present in the 
prophase oocyte and that increase in number after nuclear envelope breakdown [12]. It is 
clear that centrioles are absent in mouse oocytes and the term “acentriolar centrosomes” 
has been used to describe the MTOCs that ultimately form the spindle; however other 
researchers refer to mouse oocytes as acentrosomal to denote the formation of a 
centrosomal equivalent from a clustering of MTOCs [reviewed in 9]. Regardless of the 
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terminology used, the centrosome or MTOCs (centrosomal equivalent) material 
associated with the MTOCs contain proteins associated with centrosomes in mitotic cells, 
including γ-tubulin, pericentrin, Nuclear Mitotic Apparatus (NuMA) protein and other 
proteins [reviewed in 9]. Aurora kinase A (AURKA) appears to be central in regulating 
MTOC number during oocyte maturation [13] and microtubule motor proteins aid in the 
formation and elongation of the bipolar spindle [12]. 
During oocyte maturation, haploid eggs are produced by two successive divisions 
that are asymmetric to produce a large egg cell and smaller polar bodies. This process 
involves both the assembly of the bipolar spindle coordinated by chromatin and spindle 
positioning at the periphery, which is dependent on the interaction between actin and 
chromatin. Translocation of the spindle and chromosomes to the periphery also promotes 
differentiation of the cortex producing a microvilli-free and actin-rich zone that 
characterizes the site of polar body formation [14, 15]. 
Proteins of the 14-3-3 (YWHA) family are now known to be central mediators in 
a variety of cellular signaling pathways involved in development and growth including 
cell cycle regulation and apoptosis [16-20]. There is strong evidence from studies of the 
cell cycle in somatic cells that 14-3-3 is involved in signaling systems regulating cell 
division [21, 22]. There is also recently reported evidence from studies of Dictyostelium 
that 14-3-3 coordinates the interaction between the mitotic spindle and cytokinesis [23, 
24] as well as some evidence that 14-3-3 is associated with the mitotic apparatus in 
mammalian cells [25]. Thus, there is some indication that 14-3-3 proteins have a role in 
spindle and cytoskeleton function; however, the role of 14-3-3 proteins in mouse meiotic 
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spindle formation and function is unknown. I previously found that all seven mammalian 
isoforms of 14-3-3 are expressed in mouse ovaries, oocytes and eggs and showed that 14-
3-3η accumulates and co-localizes with α-tubulin in the region of the meiotic spindle in 
mouse eggs matured in vivo [26] suggesting that 14-3-3η has a functional role. 
In the work presented here, an in situ proximity ligation assay (PLA; introduced 
in chapter 3) was performed to determine if 14-3-3η interacts directly with α-tubulin in 
the meiotic spindle. The PLA has been used successfully to not only detect protein-
protein interactions at the single molecule level directly in cells, but also to visualize the 
actual intracellular sites of the interactions in different types of cells and tissues [27-29]. 
In the PLA method, specific primary antibodies (raised in different species) bind to target 
proteins. A pair of oligonucleotide-conjugated secondary antibodies (PLA probes) bind to 
the primary antibodies and when the PLA probes are in close proximity (<40 nm), the 
DNA strands are joined by enzymatic ligation. A circular DNA molecule is generated and 
then amplified by rolling circle amplification. The original in situ protein-protein 
interaction is revealed by the amplified DNA detected with a fluorescent probe. The PLA 
technique is sensitive, specific, and provides a high signal to noise ratio because the 
signal is amplified and close proximity of the target proteins is required. Thus, the 
method permits detection of two proteins that interact at the molecular level. 
To begin an investigation of the role of 14-3-3η in spindle formation, experiments 
were performed to reduce the 14-3-3η protein in mouse oocytes by interfering with 
translation of the 14-3-3η message. A number of techniques that rely on reducing protein 
expression by RNA interference have been effective in identifying key protein functions 
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in oocytes, eggs and early embryos of mice and other species. These techniques include 
RNAi-mediated methods, including RNAi transgenic approaches [30-34]; however, I 
chose to study the role of 14-3-3η in meiotic spindle formation during oocyte maturation, 
by reducing the synthesis of 14-3-3η protein by intracellular microinjection of a 
translation-blocking morpholino oligonucleotide against 14-3-3η. 
Morpholino oligomers are small sequences of synthetic nucleotides consisting of 
about 25 standard nucleic acid bases attached to morpholine rings (rather than ribose 
rings) with a phosphorodiamidate non-ionic linkage instead of a phoshodiester linkage 
(giving the oligonucleotide a net neutral charge) [35]. While a number of methods have 
been developed to block gene expression at the level of the mRNA, including those using 
the ability of cellular RNAase H-dependent methods and siRNA techniques, the 
development of morpholinos to knock down proteins by blocking translation has 
overcome a number of limitations associated with the other techniques. With the 
appropriate experimental controls [36], morpholinos have a number of advantages 
including specificity resistance to nucleases. Morpholinos appear to have few off-target 
interactions and little non-antisense activity because they are specific (binding to at least 
13–14 contiguous bases) and the neutral charge gives little interaction with other RNA 
species or cellular proteins [37, 38]. The feasibility of using morpholino oligomers to 
block a target gene’s function in mouse has been established through a morpholino 
phenocopy of the easily discernible and well-characterized mouse mos−/− phenotype 
[39]. Morpholino oligonucleotides have been successfully used to inhibit translation of 
specific genes in embryos of zebrafish [40] and Xenopus [41]. Similarly, experiments 
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utilizing morpholino antisense oligomers have implicated a number of proteins in mouse 
oocyte meiotic maturation [39, 42-50]. 
In this study, using several methods, 14-3-3η is shown to interact with α-tubulin 
especially in the meiotic spindles in mouse oocytes and eggs. Moreover, morpholino-
mediated knockdown of 14-3-3η provides evidence that 14-3-3η is required for normal 
meiotic spindle assembly during mouse oocyte maturation. 
 
 
Results and Discussion 
 
The protein 14-3-3η co-localizes with α-tubulin at the metaphase II spindles in 
mouse eggs 
It was previously demonstrated that 14-3-3η is uniformly distributed in fully 
grown, immature mouse oocytes with greater distribution in the cytoplasm than in 
germinal vesicles, and that it accumulates at the metaphase II spindle of eggs matured in 
vivo [26]. In that study, indirect immunofluorescence, utilizing a rabbit antibody directed 
against the cross-reacting N-terminal sequence of sheep 14-3-3η, demonstrated that 14-3-
3η, but none of the other 14-3-3 isoforms, is concentrated at the metaphase II spindle and 
that 14-3-3η appeared to co-localize with α-tubulin. In the present study, this observation 
has been confirmed by detecting prominent accumulation of 14-3-3η at the spindle region 
in 20 of 23 in eggs matured in vitro (Figure 1). These cells, in anticipation of the 
experiments to follow, were held as oocytes in an arrested state at prophase I for 24 hours 
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with 0.1 mg/ml dibutyryl cAMP (dbcAMP) in the media. After 24 hours the dbcAMP 
was removed to allow maturation, and the cells were examined about 13 hours later, a 
time at which mature eggs are formed. The rabbit antibody targeted against the N-
terminal sequence of 14-3-3η was used for the remaining experiments in this chapter. 
. 
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Figure 1. The 14-3-3η protein accumulates at the metaphase II spindle of the mouse 
egg matured in vitro. Cells were fixed, permeabilized and immunolabeled for confocal 
double immunofluorescence using a primary antibody against the 14-3-3η protein (red) 
and an antibody to α-tubulin (green) and counterstained with Hoechst 33342 (blue) to 
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visualize DNA. (A-D) A representative in vitro-matured egg cell that was held in 
prophase I arrest for 24 hours, released from the arrest and examined at 13 hours with a 
rabbit antibody recognizing the N-terminal end of the 14-3-3η protein (C). The merged 
image is an overlay of immunofluorescence images from the three channels. Scale bar 
represents 10 μm. 
 There are some differences in the shape and size of the meiotic spindle during in 
vivo maturation compared to in vitro maturation, for example, it has been reported that in 
vivo-matured eggs have pointed spindles with compact localization of γ-tubulin at the 
spindle poles. In contrast, in vitro-matured eggs exhibited large more barrel shaped 
spindles with γ-tubulin distributed over more spindle microtubules [51]. These 
observations, however, do not represent fundamental differences in spindle function in as 
much as chromosomes segregate and polar bodies form in both cases. As our studies here 
rely on in vitro maturation, it was first confirmed that 14-3-3η accumulates in the spindle 
of in vitro matured eggs using the same rabbit antibody used in the previous study of 
mature, ovulated eggs. 
 
The protein 14-3-3η accumulates and co-localizes with α-tubulin at both meiosis I 
and II spindles during in vitro mouse oocyte maturation 
Given that 14-3-3η is concentrated at the metaphase II spindle of mouse eggs, the 
co-localization of 14-3-3η with α-tubulin was examined during the process of in vitro 
oocyte maturation by additional confocal indirect immunofluorescence studies. Oocytes 
were collected in HEPES-buffered MEM α containing dbcAMP, and then allowed to 
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mature in vitro by incubation in bicarbonate-buffered MEM α without dbcAMP for 4.5 
hours (early spindle formation), 7.5 hours (MI pro-metaphase), 9 hours (MI metaphase) 
and 12 hours (MI telophase to MII metaphase) before fixation [6]. I examined 15 cells at 
each stage of maturation and found the following pattern in all cells examined. The 14-3-
3η protein was found to be present throughout the cytoplasm during oocyte maturation at 
all stages (Figure 2A-J). Accumulation of 14-3-3η at the meiotic spindle region was 
detected around prometaphase I at 7.5 hours after release from prophase I arrest (Figure 
2C-D). By 9 hours of maturation, a marked co-localization of 14-3-3η with α-tubulin was 
observed at the metaphase I spindle with condensed chromosomes aligned at the mid-
spindle region (Figure 2E-F). At telophase I, prominent accumulation of 14-3-3η was 
found at the broad midbody microtubules during formation of the first polar body (Figure 
2G-H). At the end of 12 hours of the maturation, telophase I is followed quickly by the 
formation of the metaphase II spindle (Figure 2I) and again 14-3-3η was shown to 
accumulate in the region of the MII spindle (Figure 2I-J) as well as associated with α-
tubulin in the first polar body (Figure 2K-L). 
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Figure 2. The 14-3-3η protein accumulates and co-localizes with α-tubulin in MI and 
MII meiotic spindles during oocyte maturation. Representative cells were fixed, 
permeabilized and immunolabeled for confocal microscopy during oocyte in vitro 
maturation at the times indicated. The left column shows the merged images of α-tubulin 
(green) and the counterstain Hoechst 33342 (blue) to visualize the DNA. The right 
column shows each corresponding image of the 14-3-3η protein (red). (A-H) Paired 
confocal images at a single confocal plane of the spindle region of representative cells at 
the times indicated. (I-L) Representative egg imaged at the plane of metaphase II spindle 
(I, J) and at a different confocal plane to show the first polar body (K, L) attached to the 
same egg cell. Scale bars represent 10 μm. 
 
These experiments suggest a functional role of a specific isoform of 14-3-3 
proteins, 14-3-3η, in the formation of normal meiotic spindles during mouse oocyte 
maturation. The marked accumulation of 14-3-3η at the metaphase II meiotic spindles in 
eggs was observed by immunofluorescence staining of the protein. The gradual 
accumulation and co-localization of 14-3-3η at the meiosis I and II spindles observed 
during mouse oocyte maturation in vitro, suggest that the 14-3-3η protein may be 
involved with concomitant formation of the spindles by directly or indirectly influencing 
the assembly of the spindle microtubules. 
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The 14-3-3 proteins are known to bind to a large number other proteins to regulate 
many cellular processes [16, 19]; however, the role of 14-3-3 proteins in development of 
the mammalian meiotic spindle has not yet been examined. Some studies have suggested 
that isoforms of 14-3-3 are associated with tubulin and may play a role in microtubule 
assembly and spindle formation in mitosis.  Proteomic analysis of interphase and mitotic 
HeLa cells demonstrated that 14-3-3 proteins interact with α- and β-tubulin in both 
interphase and mitotic cells [20, 52, 53].  The 14-3-3γ and 14-3-3ε proteins have been 
reported to be localized in the centrosomes and mitotic spindle of mouse leukemic FDCP 
cells and at least one isoform is associated with the centrosomes and spindle of mouse 
3T3 cells [25].  The 14-3-3 protein has also been found to interact with ENDOSPERM 
DEFECTIVE 1 (EDE1), a plant microtubule-associated protein essential for plant cell 
division and for microtubule organization in endosperm [54].  The potential interaction of 
14-3-3η with α-tubulin was further explored by extending the indirect 
immunofluorescence co-localization studies to examine the direct interaction of 14-3-3η 
with α-tubulin at the molecular level, as described below. 
 
Evidence for direct association of 14-3-3η with α-tubulin and accumulation of the 
interactions at the metaphase II spindle 
The observation that 14-3-3η co-localizes with α-tubulin in the double labeling 
immunofluorescence experiments does not necessarily mean that the 14-3-3η protein is 
interacting with α-tubulin directly. Protein-protein interactions at the single molecule 
level were studied using the in situ proximity ligation assay (PLA) and documented the 
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distribution of intracellular sites of the interactions between 14-3-3η and α-tubulin in 
mouse eggs matured in vitro. The in situ PLA revealed some interactions (noted by 
distinct bright fluorescent reaction spots) of 14-3-3η with α-tubulin throughout the 
cytoplasm of all mouse eggs matured in vitro, along with a prominent accumulation of 
the interaction sites at the meiotic spindles (Figure 3A-E) in 16 out of 18 eggs examined. 
In addition, an abundance of the interaction sites was noted along the cell cortices next to 
the spindles of those eggs studied (Figure 3C,E). These observations indicate that 14-3-
3η interacts with α-tubulin in mouse eggs and that such interactions are dramatically 
more prevalent in the region of the meiotic spindle as would be predicted by the co-
localization and enhanced concentration indicated by the immunofluorescence 
experiments. 
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Figure 3. The 14-3-3η protein interacts directly with α-tubulin. (A-C) A single 
confocal section through the region of the meiotic spindle of a representative in vitro-
matured egg. Sites of protein 14-3-3η and α-tubulin are indicated by the green fluorescent 
spots (B). The cell was counterstained with Hoechst 33342 (blue) to visualize DNA (A) 
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and the merged image is shown (C). (D) The non-confocal, brightfield image of this cell 
and spindle (white box). (E) A compressed stack of seven consecutive confocal scans 
performed at 2 μm intervals from the bottom of the spindle to its top. A marked 
accumulation of the in situ PLA sites of interaction of 14-3-3η with α-tubulin was 
observed at the meiotic spindles in eggs and along the egg cortices about the spindles 
(highlighted by the white box). (F-H) A representative control egg processed 
simultaneously for in situ PLA by identical procedure, in absence of the primary 
antibodies for 14-3-3η and α-tubulin. (F) The non-confocal, brightfield image of the cell 
and its spindle (white box). (G) A single, confocal fluorescence scan through the spindle 
region of the egg cell showing no in situ PLA fluorescent reaction spot. (H) A 
compressed stack of all confocal scans from the bottom of the egg cell to its top, showing 
complete absence of in situ PLA fluorescent reaction spots. Background fluorescence was 
minimal (G, H). Scale bars represent 10 μm. 
 
No in situ PLA fluorescent reaction spots were detected throughout control mouse 
eggs processed simultaneously following the identical procedure but without addition of 
the primary antibodies (Figure 3F-H). In the absence of primary antibodies there is no 
ligation and rolling circle amplification of the PLA probes that is necessary for detection. 
In addition, no background fluorescence from unhybridized probes is detected in confocal 
sections imaged at the same confocal setting as the experimental cells (Figure 3G) and 
only a very slight background is apparent in the compressed Z images (Figure 3H). 
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It is not yet known if 14-3-3η and tubulin form part of a larger macromolecular 
complex. Additional studies may indicate if 14-3-3η also interacts with other proteins at 
the spindle and elsewhere in the cell. The 14-3-3 protein forms functional homodimers or 
heterodimers of different isoforms [55, 56]. In some cases, the separate isoforms may 
have overlapping functions and may be exchangeable in binding to a target protein either 
as homodimers of isoforms or heterodimers of mixed isoforms. In other cases there may 
be a specific isoform preference for interaction with some target proteins [57]. There was 
no evidence for accumulation of any of the other six 14-3-3 isoforms at the meiotic 
spindle in mature mouse eggs [26], suggesting that the interaction that was observed, is 
mediated by 14-3-3η homodimers, and that other isoforms are not specifically associated 
with the spindle. Moreover, as shown by the following experiments, a reduction in 14-3-
3η protein alone causes defects in spindles, indicating that there is no functional overlap 
with the other 14-3-3 isoforms. 
 
A 14-3-3η translation-blocking morpholino causes absence or deformation of the 
meiosis I spindle during in vitro mouse oocyte maturation 
The results described above clearly demonstrated that 14-3-3η is closely 
associated with α-tubulin during the formation of meiosis I and II and spindles. To begin 
to understand the functional role of 14-3-3η in the formation of meiotic spindles during 
mouse oocyte maturation, a series of experiments were done in which the amount of 14-
3-3η protein in the oocyte was effectively reduced by inhibiting translation of the 14-3-3η 
message. While in prophase I arrest, GV-intact oocytes were microinjected with a 
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translation-blocking morpholino oligonucleotide against 14-3-3η at a final intracellular 
concentration of 0.1 mM and held for 24 hours in prophase arrest to permit a reduction of 
the existing 14-3-3η protein. The oocytes were then released from the meiotic arrest, 
allowed to mature in vitro, fixed at 13 hours after the release from meiotic arrest and 
examined by confocal indirect immuno-fluorescence. 
Cells underwent germinal vesicle breakdown, but reduction of 14-3-3η protein 
caused a substantial decrease in the number of cells that formed a normal bipolar spindle 
during first meiosis. Only 24% of the cells injected with the morpholino oligonucleotide 
targeting 14-3-3η formed an apparently normal bipolar spindle, while in 76% of the cells 
the spindle was absent or deformed with no polar body formation (Figure 4A). 
Immunofluorescence images of two representative morpholino-injected cells that formed 
no spindle are shown in Figure 5A-H. It can be seen that, in these cases, the DNA is 
clumped (Figure 5A,E), the spindle microtubules are absent (Figure 5B,F), and there is 
no accumulation of 14-3-3η around the chromatin or in the region where the spindle 
should be forming (Figure 5C,G). The spindle regions of three representative cells with 
deformed meiotic spindle are shown in Figure 5I-T. In these cases, the DNA is partially 
clumped (Figure 5I,M,Q) and the spindle is unipolar, disorganized, or apolar and 
incompletely formed (Figure 5J,N,R). Again, there is little or no accumulation of 14-3-3η 
detected in these incompletely formed spindle regions (Figure 5K,O,S). None of these 
cells injected with the 14-3-3η morpholino formed polar bodies, indicating that such 
cells, with absent or deformed meiosis I spindles, do not progress to cytokinesis and first 
polar body formation. 
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Figure 4. Summary of experimental results on meiotic spindle structure following 
injection of the 14-3-3η morpholino and control conditions. As described in Methods, 
oocytes were held in prophase I meiotic arrest for 24 hours, allowed to mature in vitro for 
13 hours and then processed for immunofluorescence and confocal microscopy to 
examine the spindle structure. (A) For each condition, the number of cells with a normal 
spindle, deformed spindle or no spindle is represented graphically as a percentage of the 
total number of cells examined. Light grey, spindle absent; dark grey, deformed spindle; 
black, normal spindle. The number of cells with absent, deformed or normal spindles out 
of the total number of cells studied for each injection condition is indicated alongside the 
corresponding percentage bars. Representative images of cells displaying the three 
categories are presented in Figure 5 and 6. (B) Fisher’s Exact test comparing the 
experimental group (14-3-3η morpholino injection) and combined controls for the 
absence of spindles or presence of at least some spindle. (C) Fisher’s Exact test 
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comparing the experimental group (14-3-3η morpholino injection) and combined controls 
for deformed or normal spindle. MO, morpholino oligonucleotide. 
 
 
 
Figure 5. Microinjection of a morpholino against 14-3-3η causes absence or 
deformation of meiotic spindles in cells matured in vitro. Oocytes were injected with 
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0.1 mM 14-3-3η morpholino, held for 24 hours in prophase I arrest, released from the 
arrest for 13 hours, fixed, permeabilized and immunolabeled for confocal 
immunofluorescence with an antibody to α-tubulin (green), the antibody to 14-3-3η 
protein (red), and counterstained with Hoechst 33342 (blue) to visualize the DNA. The 
panel on the far right is the merged overlay of immunofluorescence images from all three 
channels. (A-D and E-H) The upper two rows (cells 1 and 2) are images of two 
representative cells that have clumped DNA, no spindle and no 14-3-3η accumulation. (I-
L, M-P, and Q-T) The lower 3 rows (cells 1–3) are representative images of cells that 
have deformed spindles, disorganized DNA and no accumulation of 14-3-3η at the 
spindle region. None of these cells injected with the 14-3-3η morpholino formed a first 
polar body, indicating that the disrupted spindles shown here are MI spindles. Scale bars 
represent 10 μm. 
 
As indicated by indirect immunofluorescence, some 14-3-3η protein was detected 
throughout the cytoplasm of eggs matured from oocytes microinjected with the 
morpholino against 14-3-3η mRNA (Figure 5C, G, K, O and S). This may be residual 
protein produced before the morpholino injection as well as some protein translated from 
14-3-3η mRNA not completely blocked by the morpholino. It is not possible to make a 
quantitative comparison of 14-3-3η protein content using fluorescence microscopy 
because, while controls were imaged along with the experimental cells, there will be 
small inherent differences in primary and secondary antibody concentration and binding 
and the confocal optics may be slightly different. Clearly however, though some of the 
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protein might be present in the cytoplasm, the absence of 14-3-3η accumulation at the 
meiotic spindle is striking, indicating a reduction in the protein that is targeted to the 
spindle. Moreover, the reduction in the 14-3-3η protein around the DNA correlates with 
the absence or abnormal formation of the spindle. 
There will be some variability in the 14-3-3η protein concentration and knock-
down effects. The amount of 14-3-3η protein may have been sufficient to permit spindle 
formation in the 24% of 14-3-3η morpholino-injected cells categorized as having a 
spindle that appeared normal. Polar bodies were observed to be associated with about half 
(7/13) of these cells indicating the cells proceeded to metaphase II. Other cells had no 
adhering polar body. This suggests that these cells formed an apparently normal 
metaphase I spindle, but did not continue with cytokinesis, which could be the case. 
However, the polar body sometimes breaks within the zona pellucida surrounding mature 
eggs and the polar body often becomes dissociated when zona-free eggs are pipetted 
through processing media drops, so that by the time these cells are examined carefully 
with confocal microscopy the polar body of a mature metaphase II egg may be absent. 
Therefore the small percentage of cells with a normal spindle may have proceeded to 
metaphase II or stopped at metaphase I. In any event, the 14-3-3η morpholino injection 
prevents spindle formation or caused abnormal spindles in about 76% of cells injected. 
The limitation in the knockdown procedure to completely eliminate the 14-3-3η protein 
can be overcome by gene knockout experiments and our lab is currently developing a 
conditional 14-3-3η knockout mouse.  
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For comparison with the 54 experimental cells injected with the morpholino 
against 14-3-3η, a total of 51 eggs matured in vitro from oocytes injected with several 
control solutions, were examined. Like the experimental cells, these oocytes were 
injected, held in arrest for 24 hours and then allowed to mature. I also examined 23 
uninjected cells treated in the same manner. The results are summarized in Figure 4 and 
representative images are shown in Figure 6. For the series of injected control cells, 86% 
had normal metaphase II spindles and, for the uninjected cells, 87% had normal 
metaphase II spindles (compared to only 24% of cells injected with the 14-3-3η 
morpholino, as indicated before). 
 
 
132 
 
 
 
 
Figure 6. Representative control eggs matured in vitro from injected oocytes, 
showing normal, bipolar meiotic spindles. (A-D) Images of an oocyte injected with 
0.01 mM of the inverted 14-3-3η morpholino. (E-H) Images of an oocyte injected with 
0.01 mM the 14-3-3γ morpholino. (I-L) Images of an oocyte injected with 10 pL of 
deionized water. In all cases these oocytes, representative of others (see Figure 4) both 
injected and uninjected, were held for 24 hours in prophase arrest, released from arrest 
for13 hours, fixed, permeabilized and immunolabeled for confocal immunofluorescence 
with an antibody to α-tubulin (green), the antibody to 14-3-3η protein (red), and 
counterstained with Hoechst 3342 (blue) to visualize DNA. The panel at the far right is 
the merged overlay of immunofluorescence images from all three channels. In all cases, 
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the spindle appears normal and 14-3-3η accumulates at the spindle. PB, first polar body. 
MO, morpholino oligonucleotide. Scale bars represent 10 μm. 
 
One series of control experiments utilized the inverted form of the morpholino 
oligonucleotide against 14-3-3η mRNA; a panel of immunofluorescence images of a 
representative egg cell is shown in Figure 6A-D. The inverted morpholino cannot bind to 
the 14-3-3η mRNA and should not knockdown protein synthesis. In such cells, the 
metaphase II spindle formed, 14-3-3η accumulated at the metaphase II spindle and the 
cell completed first polar body formation. Some cells were also injected with a 
translation-blocking morpholino targeting 14-3-3γ (YWHAG). This 14-3-3 isoform is 
known to be present in the mouse oocyte and mature egg, though it does not accumulate 
in the egg spindle region [26]. Injection of an equivalent amount of this morpholino did 
not disrupt spindle formation nor seemed to affect oocyte maturation; a representative 
egg cell is shown in Figure 6E-H. Finally, since the morpholinos were dissolved in 
deionized water, some mouse oocytes were microinjected with an equivalent amount of 
deionized water alone. When treated in the same manner as the experimental cells, these 
cells formed normal metaphase II spindles (Figure 6I-L). 
Statistical analysis of 2×2 contingency tables using Fisher’s Exact test validated 
the significant differences between the experimental and control groups (Figure 4B, C). 
Pairwise comparison across the four control groups revealed no significant difference 
among them; as a result, all control groups were combined. When the absence of spindles 
is compared to the presence of at least some spindle microtubules between the 
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experimental group and combined controls, the two-tailed P value is less than 0.0001. 
When the presence of deformed spindles is compared to the presence of normal spindles 
between the experimental group and the combined controls, the two-tailed P value is less 
than 0.0001. The analysis reveals a very strong statistical difference between the 14-3-3η 
morpholino injection group and controls when the number of absent spindles is scored 
(Figure 4B) and a very strong statistical difference between the 14-3-3η morpholino 
injection group and controls when the number of deformed spindles is scored (Figure 
4C). Each analysis indicates that injection of 14-3-3η morpholino blocks or disrupts 
spindle formation. 
The results of microinjection of the translation-blocking morpholino 
oligonucleotide against 14-3-3η confirms that this particular isoform of 14-3-3 is 
essential for meiosis I spindle formation. Except for some cells in which the 14-3-3η 
morpholino may have been less effective, the majority of cells form no spindle or a 
deformed spindle when examined 13 hours after release from meiotic arrest. In those 
cases, the spindle and chromosomes do not resemble any of the transition stages we 
would expect to see if the spindle formation were merely delayed. Based on live cell 
imaging of spindle formation in mouse eggs, the spindle forms from a collection and 
expansion of microtubule organizing centers that aggregate in a ball just after germinal 
vesicle breakdown. A bipolar spindle forms with progressive clustering of MTOCs and 
activity of motor proteins. During this process, individual condensed bivalent 
chromosomes form during the initial contacts with microtubules. Thus the chromosomes 
remain individualized throughout the process of spindle formation [12]. The absent or 
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deformed spindles observed in 14-3-3η morpholino-injected cells do not represent 
transitional states. Aggregating MTOCs and individualized condensed chromosomes 
should be present continuously after germinal vesicle breakdown. Instead, the 14-3-3η 
morpholino injections show that spindle formation is prevented and that the DNA forms a 
clump in the absence of a spindle or if the spindle is abnormally formed. When maturing 
oocytes are treated with colchicine [14] or nocodazole [12] to depolymerize 
microtubules, the spindle doesn’t form and the chromosomes collapse into a single mass 
very similar to the appearance of the DNA that were seen in oocytes injected with 14-3-
3η morpholino. Interestingly, one or several chromosome masses move to the cortex in 
oocytes treated with colchicine during oocyte maturation [14] as were also observed in 
my experiments (Figure 5A-H). Thus our results are somewhat analogous to the 
inhibition of spindle formation by microtubule depolymerizing agents, but we do see in 
some cases a partial, imperfect spindle associated with a chromatin mass of indistinct 
chromosomes (Figure 5I-T). These results suggest that 14-3-3η is required at a sufficient 
concentration to enable the aggregation of MTOCs to form a complete bipolar spindle. 
In the absence of spindle formation and first polar body formation, the oocyte 
would not proceed to metaphase II. We do not yet know if reducing 14-3-3η protein 
alters other cytoplasmic maturation events that would affect the ability of the cell to be 
fertilized or develop a polyspermy block characteristic of a normal metaphase II-arrested 
egg. Nor do we know if more subtle changes in 14-3-3 activity and spindle structure 
might be associated with aneuploidy. There may be some changes in the spindles of 14-3-
3η morpholino-injected cells in which we see an apparently normal looking spindle that 
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could lead to aneuploidy or other developmental defects after fertilization. It is known for 
mammalian eggs that maintenance of spindle integrity is important in preventing 
aneuploidy and that aneuploidy in meiosis I is common and increases with maternal age 
in humans [reviewed in 9, 10]. 
With the morpholino-mediated knockdown of the 14-3-3η isoform, other 
isoforms, though present, do not appear to substitute or compensate for the absence of 14-
3-3η, indicating that 14-3-3η is the central 14-3-3 protein required for normal spindle 
formation. The 14-3-3 proteins have been implicated in controlling mitosis in somatic 
cells; however the exact correspondence of regulatory mechanisms by 14-3-3 in somatic 
cells or oocytes of other species with the mouse oocyte will need to be explored further in 
the light of our findings. For example, in somatic (HeLa) cells, 14-3-3η depletion appears 
to disrupt chromosome segregation and disrupt mitosis, leading to cell death. The identity 
of the 14-3-3η target proteins in these cells was not examined, but depletion of 14-3-3η 
also sensitizes the cells to several microtubule inhibitors, suggesting an interaction with 
tubulin [58]. 
Our results indicate a specific interaction of 14-3-3η with α-tubulin in the meiotic 
spindle and that this interaction is required for normal spindle formation. It may be that 
14-3-3η interacts with other proteins individually or in a complex with tubulin. In 
addition to playing a role in spindle formation, 14-3-3η could also function in other 
maturation events apart from a direct interaction with tubulin and formation of the 
spindle. The 14-3-3 proteins are known to be important in regulating mitosis through 
interactions with CDC25 (cell division cycle 25) proteins [22, 59-62] and some evidence 
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implicates 14-3-3 proteins in serving to maintain meiotic arrest at prophase I in mouse 
oocytes [63,64]. The experiments reported here indicate that reduction of 14-3-3η or 14-
3-3γ protein synthesis by morpholino injection, under the conditions used, does not 
interfere with the resumption of meiosis following the removal of dbcAMP since oocyte 
nuclear envelope breakdown occurs normally. As described before, I also investigated 
which of the 14-3-3 proteins is involved in the regulation of cell cycle control proteins, 
particularly CDC25B (cell division cycle 25B) phosphatase. 
The 14-3-3 proteins have also been found to regulate cell mechanics and 
cytokinesis in somatic cells by integrating key cytoskeletal components. In 
Dictyostelium, for example, where only one 14-3-3 isoform is known to be present, 
partial knockdown of 14-3-3 protein does not appear to alter spindle formation during 
mitosis, though it does cause cytokinesis defects resulting in multi-nucleated cells [23]. 
Similar mechanical events in meiosis would suggest a role for 14-3-3 as well [65]. It has 
been suggested that the central spindle found in anaphase of animal cells during mitosis is 
required for formation of the contractile ring. A number of microtubule-bundling and 
stabilizing factors are required for formation of the central spindle; among them is 
centralspindlin which is regulated by Aurora B and 14-3-3. In this case, 14-3-3 
apparently acts to sequester centralspindlin, maintaining it in an inactivate state until it is 
phosphorylated by Aurora B, and is released from 14-3-3 to form centralspindlin clusters 
in the central spindle [66]. The characteristic asymmetric cell division in meiosis 
apparently requires different organization and regulation though, for example, the Aurora 
kinases are involved with the regulation of cytokinesis in oocytes [67, 68]. Additional 
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studies may reveal possible interactions of 14-3-3 with target proteins associated with 
cytokinesis. 
 
 
Materials and Methods 
 
Collection of oocytes and eggs 
All mice were housed and used at Kent State University under an approved 
Institutional Animal Care and Use Committee protocol following the National Research 
Council’s publication Guide for the Care and Use of Laboratory Animals. Oocytes and 
eggs were collected as previously described [69]. Adult (2–3 months old) CF1 mice were 
injected with 7.5 IU eCG (G4877, Sigma) and, 44–48 hours later, the ovaries were 
removed and repeatedly punctured with a 26-gauge needle to rupture follicles. Cumulus 
cell-enclosed oocytes were isolated and the cumulus cells were removed by repeated 
pipetting though a small-bore pipette. Fully-grown oocytes with intact nuclei (germinal 
vesicles) were collected and cultured in Minimum Essential Medium α modification 
(MEM α) (12000–014, Invitrogen) containing 120 U/ml penicillin G (P4687, Sigma), 50 
μg/ml streptomycin sulfate (S1277, Sigma), 0.24 mM sodium pyruvate (P-4562, Sigma), 
0.1% polyvinyl alcohol (P-8136, Sigma), and buffered with 20 mM HEPES to pH 7.2. 
Throughout these experiments with oocytes, except where indicated, 0.1 mg/ml dibutyryl 
cAMP (D0627, Sigma) was added to prevent spontaneous oocyte maturation. Mature, 
metaphase-II arrested eggs were obtained from adult CF1 mice 13 hours after injection of 
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7.5 IU hCG (CG10, Sigma) which was preceded by a priming injection of 7.5 IU eCG 
injection 48 hours earlier. Cumulus cells were removed with 0.3 mg/ml hyaluronidase 
(H4272, Sigma). Cumulus-free eggs were collected in MEM α. 
 
Immunofluorescence and confocal microscopy 
Cells were briefly treated in acid Tyrode’s solution solution (0.14 M NaCl, 3 mM 
KCl, 1.6 mM CaCl2.2H2O, 0.5 mM MgCl2.6H2O, 5.5 mM glucose, and 0.1% PVA, pH 
2.5) to remove zonae pellucidae. Cells were then fixed in freshly prepared 3.7% 
paraformaldehyde for 30–60 minutes, washed in 0.1% PVA in PBS, permeabilized with 
1% triton X-100 (X100, Sigma), washed in 0.1% PVA in PBS and in blocking buffer 
containing 5% normal donkey serum (017-000-121, Jackson Immunoresearch), and 
incubated at 4°C overnight simultaneously with rabbit anti-14-3-3η (AHP1046, AbD 
Serotec) and rat anti-α-tubulin (sc-69970, Santa Cruz Biotechnology), each diluted 1:200 
in blocking buffer containing 1% normal donkey serum. This rabbit anti-14-3-3η was 
made against a synthetic peptide corresponding to acetylated N-terminal sequence of 
sheep 14-3-3η and was used to detect 14-3-3η in mouse oocytes and eggs by Western 
blotting and immunofluorescence [26] and has been used effectively in other cells to 
detect 14-3-3η [70]. The cells were then washed in 1% blocking buffer and incubated 
simultaneously in DyLight™ 549 donkey anti-rabbit (711-505-152, Jackson 
ImmunoResearch) and FITC-conjugated goat anti-rat (711-505-152, Jackson 
ImmunoResearch), each diluted 1:200 in blocking buffer containing 1% donkey serum 
for several hours, washed again in blocking buffer, counter stained with the DNA-
140 
 
 
 
staining Hoechst 33342 (B 226, Sigma) at a final concentration of 1.0 μg/ml and 
transferred into an anti-fade solution (SlowFade®, S-2828, Invitrogen) diluted 1:1 in PBS 
with 0.1% PVA. All cells were imaged with the Olympus FluoView FV1000 confocal 
microscopy system (60X oil immersion lens with various confocal zooms; the scale bar 
on the images indicates the final magnification). Images were captured at multiple 
confocal planes. The representative images shown here are primarily images at the plane 
of the meiotic spindles in the cells examined. 
For this experiment and all of the following immunocytochemical staining 
experiments, some cells were processed through the identical procedure, but omitted the 
primary antibodies (not shown). Minimal or no background fluorescence was noted, 
indicating no nonspecific binding of the secondary antibodies when cells were imaged at 
the confocal settings used with the experimental cells. 
 
Time course assay of oocyte maturation in vitro to detect accumulation of 14-3-3η at 
meiotic spindles 
Oocytes were isolated from adult (2–3 months old) CF1 mice as outlined above. 
All oocytes were then removed from the HEPES-buffered MEM α containing dibutyryl 
AMP and allowed to mature in vitro by incubation in bicarbonate-buffered MEM α 
(M4526, Sigma) containing 1X Antibiotic-Antimycotic (15240–062, Invitrogen) and 
0.001 g/ml polyvinyl alcohol (P-8136, Sigma) and containing no dbcAMP. Groups of 
cells from the same batch of oocytes were allowed to mature in vitro and then were fixed 
at 4.5 hours, 7.5 hours, 9 hours and 12 hours. The cells were then processed for double 
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immunofluorescence staining with rabbit anti-14-3-3η and rat anti-α-tubulin along with 
staining of chromosomes with Hoechst dye and imaged by confocal microscopy, as 
described before. At each time point, 15 different cells were examined. 
 
In situ proximity ligation assay 
The Duolink In Situ PLA process (Olink Bioscience) allows visualization of sites 
of interaction between two proteins within cells in situ. Oocytes were collected and then 
maintained in bicarbonate-buffered MEM α containing 0.1 mg/ml dbcAMP in a 
humidified chamber with 5% carbon dioxide at 37°C. After 24 hours the media was 
replaced with bicarbonate-buffered MEM α without dbcAMP releasing the oocyte from 
meiotic arrest. At 13 hours the in vivo matured eggs were fixed, permeabilized and 
processed for in situ PLA using the manufacturer’s protocol and solutions modified to 
accommodate the standard method of manipulating eggs in media drops under oil. Cells 
were incubated overnight at 4°C simultaneously in rabbit anti-14-3-3η (AHP1046, AbD 
Serotec) and goat polyclonal antibody to human α-tubulin (03–15500, American 
Research Products), each diluted 1:200 in Duolink antibody diluent. Following four 
washes in the Duolink wash buffer A, the cells were incubated in Duolink PLUS, anti-
rabbit and Duolink MINUS, anti-goat PLA probes (1:5 dilution in Duolink antibody 
diluent) for two hours in a humidified chamber at 37°C. Cells were then washed twice in 
Duolink wash buffer A, incubated with ligase-ligation solution for 30 minutes in a 
humidified chamber at 37°C, washed two more times in Duolink wash buffer A, 
incubated in polymerase-amplification solution (for rolling circle amplification of the 
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DNA strands attached to the PLA probes) for 100 minutes in humidified chamber at 
37°C, washed twice in 1X Duolink wash buffer B and once for 10 min in 0.01X Duolink 
wash buffer B containing Hoechst 33342 dye (1 μg/mL). The eggs were then transferred 
to a solution of SlowFade® (S-2828, Invitrogen) diluted 1:1 in PBS with 0.1% PVA for 
imaging for confocal imaging. Z-stack images of cells were collected at 2 μm intervals 
from one side of the spindle to the other. Images are presented here as a single slice or as 
a compressed Z-stack of the spindle region. The in situ PLA sites of interaction between 
14-3-3η and α-tubulin were examined in this manner in 18 different egg cells. Seven 
control eggs processed were for in situ PLA following the identical procedure, but in the 
absence of the primary antibodies; these cells had no PLA reaction spots indicating that 
there is no rolling circle amplification in the absence of the primary antibodies. 
 
Microinjections 
A translation-blocking morpholino oligonucleotide was designed to block 
translation of the mouse 14-3-3η mRNA (5’-CTGCTCTCGATCCCCCATGTCGCTC-3’, 
Gene Tools) and it was solubilized in sterile deionized water to prepare a 2 mM solution. 
The injection pipettes were beveled [71], backfilled with the injection solution and 
connected to a semi-quantitative injection system utilizing pneumatic pressure injection 
(PLI-100A Pico-Injector, Harvard Apparatus). The injection pressure and the injection 
duration were adjusted to match calibrated injection volumes determined by measuring 
the diameter and calculating the volume of the sphere of the injection solution injected 
into inert dimethylpolysiloxane (viscosity 12,500 cSt; DMPS12M, Sigma) which covered 
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a drop of HEPES-buffered MEM α containing the oocytes. Ten pL (approximately 5% of 
the oocyte cell volume) of the morpholino solution was injected into the cytoplasm of 
mouse oocytes to give a final concentration of approximately 0.1 mM within each oocyte. 
To show that the injection alone did not have an effect on oocyte maturation and 
to show that the morpholino was specifically blocking the 14-3-3η mRNA, a number of 
control experiments were done. Some mouse oocytes were injected with 10 pL of 
deionized water (the vehicle for morpholino injections). In addition, two morpholino 
controls were used that should have no effect on 14-3-3η mRNA. Of these, the first 
consisted of 10 pL of a 2 mM stock non-sense morpholino that should not bind to 14-3-
3η (5’-CTCGCTGTACCCCCTAGCTCTCGTC-3’, Gene Tools; the invert of the 
morpholino against 14-3-3η). Also, some oocytes were injected with 10 pL of a 2 mM 
solution of a translation-blocking morpholino against mouse 14-3-3γ mRNA (5’-
GGTCCACCATCTTCACAGGGCTGAA-3’, Gene Tools). This morpholino should not 
bind to 14-3-3η mRNA and serves as an additional control for the morpholino injection. 
All injections were performed in HEPES-buffered MEM α with 0.1 mg/ml dbcAMP. 
The injected oocytes and some additional control uninjected oocytes were held in 
prophase I meiotic arrest for 24 hours. The oocytes were maintained in a bicarbonate-
buffered MEM α containing 0.1 mg/ml dbcAMP in a humidified chamber with 5% 
carbon dioxide at 37°C. After 24 hours the media was replaced with bicarbonate-buffered 
MEM α without dbcAMP. The oocytes allowed to mature in vitro for 13 hours and then 
processed for immunofluorescence and confocal microscopy, as described before with 
staining for 14-3-3η, α-tubulin and DNA. Images were captured at multiple confocal 
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planes. The representative images shown are primarily images at the plane of the meiotic 
spindles or DNA in the cells examined. For each injection condition, the cells were 
classified into three categories depending on the whether the meiotic spindle was absent, 
deformed or normal in appearance. Nonparametric statistical analysis was done using 
Fisher’s exact test. First, pairwise orthogonal comparisons were made across the four 
control groups; because they were not different, they were combined for further analysis. 
The combined control group and the experimental group were compared for the absence 
of a spindle versus the presence of at least some spindle microtubules, and for presence of 
deformed spindles versus the presence of normal spindles. 
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Conclusions 
 
The study reveals the functional importance of a specific isoform of 14-3-3, 
namely 14-3-3η, in regulating meiotic spindle formation during mouse oocyte maturation 
in vitro, by morpholino-mediated knock-down of the protein. The results of the study 
indicate that 14-3-3η regulates the organization or stabilization of meiosis I spindle 
assembly and may be required for first polar body formation, thereby allowing normal 
progression to metaphase II spindle formation as well. In situ proximity ligation assays 
and confocal indirect immunofluorescence experiments demonstrate that 14-3-3η 
interacts with α-tubulin in eggs, with an accumulation of the interactions at the meiotic 
spindle. These results suggest that 14-3-3η is essential for formation of the normal 
meiotic spindle apparatus during mouse oocyte maturation in vitro by interacting, in part 
with α-tubulin to regulate the assembly of microtubules.  
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Summary and Significance 
 
The work is the first to reveal that all seven mammalian 14-3-3 protein isoforms 
are expressed in mouse eggs and ovarian follicular cells including oocytes. 
Immunofluorescence confocal microscopy of isolated oocytes and eggs confirmed the 
presence of all of the isoforms with characteristic differences in some of their 
intracellular localizations. For example, some 14-3-3 isoforms (β, ε, γ, and ζ) are 
expressed more prominently in peripheral cytoplasm compared to the germinal vesicles 
in oocytes, but are uniformly dispersed within eggs. On the other hand, 14-3-3η is 
diffusely dispersed in the oocyte, but attains a uniform punctate distribution in the egg 
with marked accumulation in the region of the meiotic spindle apparatus. 
Immunohistochemical staining detected all isoforms within ovarian follicles, with some 
similarities as well as notable differences in relative amounts, localizations and patterns 
of expression in multiple cell types at various stages of follicular development. The study 
of the differential expression of 14-3-3 isoforms in female germ cells and ovarian 
follicles provides a foundation for further investigating 14-3-3 isoform-specific 
interactions with key proteins involved in ovarian development, meiosis and oocyte 
maturation.  
To examine the interactions of 14-3-3 isoforms with CDC25B in oocytes and 
eggs, an in situ Proximity Ligation Assay was performed, that can detect protein-protein 
interactions at the single molecule level and allows visualization of the actual 
intracellular sites of the interactions. Prominent interactions of all seven 14-3-3 isoforms 
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with CDC25B were observed throughout cytoplasm and nuclei of mouse oocytes, along 
with reduced interactions for each individual isoform in eggs compared to oocytes. Co-
immunoprecipitation studies with extracts of mouse oocytes also demonstrated 
interaction of CDC25B with six 14-3-3 isoforms. Phosphorylation of CDC25B at Ser-149 
is reduced in eggs compared to oocytes. These results suggest that any of the 14-3-3 
isoforms may have the potential to hold CDC25B inactive in oocytes to maintain the 
meiotic arrest. In preliminary experiments to explore if interactions of 14-3-3 with other 
proteins are important for maintaining meiosis I arrest, oocytes were microinjected with 
0.5μg/μL R18, a synthetic non-isoform specific 14-3-3-blocking peptide. Injected oocytes 
were incubated overnight in media containing threshold concentration (0.05mg/mL) of 
dbcAMP (dibutyryl cAMP) which normally holds oocytes arrested through activation of 
PKA and phosphorylation of CDC25B and CDK1. A significant increase in germinal 
vesicle breakdown (GVBD) was observed in cells injected with R18, compared to control 
oocytes. To investigate which specific isoform(s) of 14-3-3 is/are responsible for 
maintaining the meiotic arrest, the synthesis of each 14-3-3 isoform in mouse oocytes 
was reduced by intracytoplasmic microinjection of 0.1mM translation-blocking 
morpholino oligonucleotide against the corresponding isoform mRNA. Injected oocytes 
were held arrested at prophase I for 24 hours, and then incubated overnight in media 
containing the threshold concentration of dbcAMP. GVBD was observed in a significant 
percentage (70%) of oocytes microinjected with morpholino against 14-3-3η, despite the 
presence of dbcAMP. Injection of morpholinos targeting other 14-3-3 isoforms caused 
little or no GVBD. Thus, reduction in 14-3-3η/CDC25B interaction releases the mouse 
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oocyte from meiotic arrest. These results suggest that, while all 14-3-3 isoforms interact 
with CDC25B in mouse oocytes, 14-3-3η is essential for maintaining the prophase I 
meiotic arrest. 
Immunofluorescence staining and examination of oocytes matured in vitro 
demonstrated that 14-3-3η accumulates in both meiosis I and II spindles. To explore if 
14-3-3η interacts directly with α-tubulin in meiotic spindles during mouse oocyte 
maturation, in situ proximity ligation assay was performed. This assay revealed a marked 
interaction between 14-3-3η and α-tubulin at the metaphase II spindle. To demonstrate a 
functional role for 14-3-3η in oocyte maturation, mouse oocytes were microinjected with 
a translation-blocking morpholino oligonucleotide against 14-3-3η mRNA to reduce    
14-3-3η protein synthesis during oocyte maturation. Meiotic spindles in those cells were 
studied by immunofluorescence staining of 14-3-3η and α-tubulin along with observation 
of DNA. In 76% of cells injected with the morpholino, meiotic spindles were noted to be 
deformed or absent and there was reduced or no accumulation of 14-3-3η in the spindle 
region. Those cells contained clumped chromosomes, with no polar body formation. 
Immunofluorescence staining of 14-3-3η and α-tubulin in control eggs matured in vitro 
from uninjected oocytes and oocytes microinjected with the ineffective, inverted form of 
a morpholino against 14-3-3η, a morpholino against 14-3-3γ, or deionized water showed 
normal, bipolar spindles. These findings indicate that 14-3-3η is essential for normal 
meiotic spindle formation during in vitro maturation of mouse oocytes, in part by 
interacting with α-tubulin, to regulate the assembly of microtubules.  
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Taken together, these studies elucidate significant roles of 14-3-3 proteins and 
their isoform-specific interactions with other key proteins such as CDC25B and α-
tubulin, in regulating mouse oocyte maturation. The results add to our understanding of 
the importance of 14-3-3 protein isoforms in mouse oocyte maturation and mammalian 
reproductive development. 
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Appendix of Abbreviations 
 
ABC: Avidin-Biotin Complex 
Arg: Arginine  
cAMP: Cyclic Adenosine Monophosphate 
CCNB1: Cyclin B1 
CDC25B: Cell Division Cycle 25 homolog B 
CDK1: Cyclin-Dependent Kinase 1 
cGMP: Cyclic Guanosine Monophosphate 
Cy3: Cyanin3 
DAB: 3,3' Diaminobenzidine 
dbcAMP: Dibutyryl Cyclic Adenosine Monophosphate 
DEAE: diethylaminoethanol 
eCG: Equine Chorionic Gonadotropin 
FITC: Fluorescein Isothiocyanate 
GV: Germinal Vesicle 
GVBD: Germinal Vesicle Breakdown 
hCG: Human Chorionic Gonadotropin 
HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HRP: Horse Radish Peroxidase 
MI: Meiosis I 
MII: Meiosis II 
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MEM: Minimal Essential Medium 
MO: Morpholino Oligonucleotide 
MPF: Mitosis Promoting Factor 
Na3VO4: Sodium Ortho-Vanadate 
NaF: Sodium Fluoride 
PADI6: Peptidyl Arginine Deiminase 6 
PBS: Phosphaste Buffered Saline 
PDE3A: Phosphodiesterase 3A  
PKA: Protein Kinase A 
PLA: Proximity Ligation Assay 
PMSF: Phenylmethylsulfonyl Fluoride 
PP1: Protein Phosphatase 1 
pSer: Phospho-Serine 
PVA: Polyvinyl Alcohol 
PVDF: Polyvinylidene Fluoride 
SDS-PAGE: Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
Ser: Serine 
TBS: Tris Buffered Saline 
TPCK: Tosyl Phenylalanyl Chloromethyl Ketone 
Tris-HCl: Tris-hydrohloride 
YWHA: Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein. 
